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ABSTRACT 
SAMANTHA JEAN SNOW: Ultrafine particles alter endothelial phenotype through oxidant 
signaling 
(Under the direction of Dr. Martha Sue Carraway and Dr. David Diaz-Sanchez) 
 
 Mechanisms that underlie the strong association between air pollution exposure and 
cardiovascular (CV) morbidity and mortality remain unknown.  Particulate matter (PM) is a 
major component of air pollution and ultrafine (UF) particles, which are the smallest 
diameter particle, are of particular importance in CV dysfunction caused by exposure to air 
pollution.  UF particles can deposit in the heavily vascularized region of the lung and the 
soluble components of UF particles (soluble UF) are able to cross from the lung into the 
circulation and adversely affect cells of the vasculature such as endothelial cells.  Endothelial 
cell activation, as characterized by an increase in reactive oxygen species (ROS) production, 
initiation of coagulation, and induction in inflammation, is a pathophysiological mechanism 
that could link inhaled air pollutants to vascular dysfunction.  This project will test the 
hypothesis that soluble UF cause altered endothelial cell phenotype through activation of 
oxidant signaling that mediates procoagulant and proinflammatory responses.  EA cells, an 
immortalized endothelial cell line, and primary human coronary artery endothelial cells 
(HCAEC) were assessed for their production of ROS, procoagulant activity, and 
proinflammatory responses following exposure to non-cytotoxic doses of soluble UF.  We 
show that exposure to soluble UF results in immediate increases in extra- and intracellular 
H2O2 production from NADPH oxidase (NOX) enzymes in endothelial cells.  Furthermore, 
soluble UF PM increased the expression of proinflammatory mediators and induced 
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endothelial procoagulant activity via a tissue factor (TF)-dependent mechanism.  
Pretreatment with antioxidants and NOX inhibitors attenuated the soluble UF-induced 
upregulation of the procoagulant protein TF, the proinflammatory cytokine IL-1β, and the 
oxidant stress-inducible protein HO-1, linking the procoagulant and proinflammatory 
responses to ROS formation from NOX enzymes.  These novel findings provide mechanistic 
insight into the endothelial dysfunction and enhanced thrombosis that underly increased risk 
for CV morbidity and mortality associated with air pollution exposure.   
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CHAPTER 1   
 
INTRODUCTION 
In the early 20
th
 century, a series of air pollution incidents in Meuse Valley, Belgium 
(1930), Donora, Pennsylvania (1948), and London, England (1952) illustrated the adverse 
effects individuals experience during severe air pollution episodes.  These events occurred in 
heavily industrialized cities during a meteorological inversion that concentrated the already 
severe air pollution and resulted in increased hospitalizations and elevated rates of mortality 
(Stanek et al., 2011).  These incidents raised public awareness about the severity of air 
pollution, led to new regulations across the developed world, and spurred investigators to 
conduct epidemiological and toxicological studies to establish the relationship and 
mechanisms behind air pollution exposure and adverse health effects.   
For decades, research has illustrated the association between air pollution exposure 
and adverse pulmonary effects, but it wasn’t until the 1990s when epidemiological (Dockery 
et al., 1993) and toxicological studies (Costa and Dreher, 1997) began linking air pollution 
exposure with adverse cardiovascular (CV) health effects.  Subsequent epidemiological 
studies have demonstrated that exposure to air pollution results in increased hospitalizations 
for circulatory diseases (Poloniecki et al., 1997), increased risk of myocardial infarctions 
(Peters et al., 2001), and increased risk of CV disease mortality (Pope et al., 2004).  It was 
also found that these adverse effects were more pronounced in susceptible populations, such 
as the elderly and individuals with preexisting CV or pulmonary diseases (Brook et al., 
2004).  Additional toxicological studies have shown that exposure to air pollution induced 
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systemic oxidative stress in mice (Araujo et al., 2008), accelerated atherosclerotic 
progression in susceptible mouse (Sun et al., 2005) and rabbit models (Suwa et al., 2002), 
and enhanced experimental arterial and venous platelet rich-thrombus formation in hamsters 
(Nemmar et al., 2003).    
The enactment of the Clean Air Act in 1970 required the Environmental Protection 
Agency (EPA) to set National Ambient Air Quality Standards for six criteria air pollutants 
including particulate matter (PM), ozone, carbon monoxide, sulfur dioxide, nitrogen oxides, 
and lead.  These air pollutants were deemed to be ubiquitous in the United States and were 
suspected or known to induce adverse health effects in humans or the environment (Suh et 
al., 2000).  Of these six criteria air pollutants, PM and ground level ozone present the most 
widespread threat to human health and are known to commonly exceed the federal standards 
set by the EPA (Laumbach, 2010).   
PM is categorized based on the diameter of the particle: coarse particles (PM10) are 10 
to 2.5 µm, fine particles (PM2.5) are 2.5 to 0.1 µm, and ultrafine particles (UF; PM0.1) are 
<0.1 µm.  PM is derived from an assortment of natural and manufactured sources including 
forest fires, soil, dust, volcanic emissions, vehicular exhaust, smokestacks, and other 
industrial sources (Poschl, 2005).  PM is a heterogeneous mixture with composition varying 
depending on several factors such as geographical location, time of day, season, and local 
emission sources.  Common constituents of PM include transition metals, elements, inorganic 
ions, volatile organic compounds, and polycyclic aromatic hydrocarbons that are adsorbed on 
a carbon core (Polichetti et al., 2009).  Urban UF particles are primarily associated with 
motor vehicle exhaust from both diesel and gasoline engines, but can also be formed by 
chemical reactions in the atmosphere (Sioutas et al., 2005).   
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The EPA currently monitors and regulates coarse and fine PM according to the Clean 
Air Act, but increasing evidence suggests that UF particles, which are not currently 
regulated, are of particular importance in CV effects of air pollution (Nel, 2005).   UF 
particles make up only a small portion of ambient PM by mass concentration; however, they 
constitute the majority of particle number per unit mass and have a significantly high surface 
area-to-mass ratio as compared to coarse and fine particles.  This property suggests that UF 
particles are capable of adsorbing large amounts of toxic substances on the surface.  In 
addition, the small diameter of the particle makes it more likely to deposit in the alveolar 
region of the lung due to Brownian motion and diffusion transportation (Kreyling et al., 
2004).  UF particles are also able to stay in the lung longer than the larger fine and coarse 
particles because their small diameter makes them more likely to avoid being recognized or 
phagocytized by alveolar macrophages, a critical lung defense mechanism (Gonzalez et al., 
1996).     
The specific mechanisms that explain how inhalation of PM through the lung leads to 
adverse CV health effects are still being determined.  There are three broad hypotheses that 
are currently being investigated to explain this association.  These mechanisms include 1) 
imbalance of the autonomic nervous system that leads to alterations in heart rate variability 
and cardiac arrhythmias, 2) induction of pulmonary inflammatory cytokines and reactive 
oxygen species (ROS) that induces systemic inflammation and oxidative stress, and 3) direct 
activation of cells of the vasculature from PM agents that have crossed into the circulatory 
system (Figure 1.1) (Brook, 2008).   
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Figure 1.1 
 
Figure 1.1  Broad biological pathways whereby PM may cause CV events. (Brook, 2008)  
These theories are not necessary mutually exclusive and can act in conjunction with 
one another and multiple studies have been conducted that support each of these hypotheses.  
The general pathway(s) that an exposure will initiate depends upon several characteristics of 
the exposure, including whether it is an acute or chronic exposure, whether it is a 
multipollutant or single exposure, and the size and composition of the particles if the 
exposure involves PM.  For instance, inhaled coarse and fine PM deposit in the larger 
airways of the lung, whereas UF PM deposits primarily in the heavily vascularized alveoli 
region of the lung where its components may interact with the circulatory system and thereby 
follow the third general pathway described above. 
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 It remains unclear as to whether UF sized particles can cross from the lung into the 
vasculature.  A study by Nemmar et al. exposed humans to an aerosol of radioactive 
99m
technetium (
99m
Tc) labeled UF carbon particles followed by imaging to determine particle 
distribution following inhalation (Nemmar et al., 2002).   They found a majority of the 
radioactivity remained in the lungs, but also recorded levels of radioactivity in the blood, 
urine, bladder, and liver, suggesting extrapulmonary translocation of 
99m
Tc labeled UF 
carbon particles.  These researchers have reported similar results using animal models 
following exposure to radioactive labeled UF particles (Nemmar et al., 2001).  However, 
there are several caveats to these studies.  For instance, the investigators were unable to 
detect the radioactive labeled UF particles in the blood using electron microscopy.  In 
addition, a study conducted by Mills et al., which also exposed humans to 
99m
Tc labeled UF 
carbon particles, found no evidence of extrapulmonary translocation of the radioactive 
labeled particles (Mills et al., 2006).  They instead explain the findings of Nemmar et al. by 
suggesting leaching of the radiolabel from the UF particle and/or contamination of free 
radiolabeled 
99m
Tc-pertechnetate in their aerosol, which is formed using the same generator 
but with minimal oxygen contamination.  These findings are supported by an additional study 
in which COPD patients were exposed to 
99m
Tc labeled UF carbon particles with no evidence 
of extrapulmonary translocation of the radioactive label particles (Brown et al., 2002).     
 While it is uncertain whether UF particles can enter into the systemic circulation in 
humans, it is reasonable to postulate that the soluble components of UF particles can cross 
the thin alveolar-capillary membrane and cause direct effects on cells of the vasculature.  For 
example, transition metals, major components of the soluble fraction, can translocate into the 
vasculature and extrapulmonary tissues following intratracheal instillation in rats 
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(Wallenborn et al., 2009; Wallenborn et al., 2007).  Additionally, the ability of these metals 
to translocate from the lung into the systemic circulation was dependent on their solubility in 
water (Wallenborn et al., 2007).  These water-soluble transition metals are capable of 
leaching off PM particles in the lung lining fluid and translocating into the circulation, 
possibly via metal transporters or other mechanisms, before being cleared by the liver.   
Transition metals, such as vanadium, nickel, iron, copper, chromium, and zinc, are 
major constituents of the water-soluble fraction of UF particles and may play an important 
role in the adverse cardiopulmonary effects associated with air pollution exposure (Costa and 
Dreher, 1997).  Transition metals can increase oxidative DNA damage, induce ROS 
production, activate inflammatory pathways, and induce procoagulant events in both in vitro 
and in vivo models (Prahalad et al., 2001; Sangani et al., 2010; Sorensen et al., 2005; Wu et 
al., 2002).  For example, concentrations of 7-hydro-8-oxo-2’-deoxyguanosine in lymphocyte 
DNA was shown to be correlated with elevated levels of soluble transition metals associated 
with fine PM in humans exposed to ambient air pollution (Sorensen et al., 2005).  This 
measurement has been used as a biomarker to assess oxidative damage caused by increased 
ROS production, indicating that soluble components of PM are capable of inducing oxidative 
stress following air pollution exposure.  Additionally, metal oxide nanoparticles induce 
inflammatory responses in endothelial cells (Gojova et al., 2007).  Furthermore, transition 
metals located in ambient and emission-source air pollution particles were shown to reduce 
the clotting time in whole blood, indicating that these soluble components are capable of 
inducing procoagulant events in humans following exposure (Sangani et al., 2010).  The 
mechanisms behind these adverse effects caused by the water-soluble components of air 
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pollution particles are not known, but one possibility is that the components have direct 
effects on cells of the vasculature including inducing endothelial activation.   
 Endothelial cell activation leads to increased vascular coagulation and inflammation, 
and it plays an important role in the pathogenesis of certain cardiovascular diseases including 
atherosclerosis and hypertension (Lwaleed et al., 2007; Sprague and Khalil, 2009). 
Endothelial activation is typically defined by five principal changes that occur including loss 
of vascular integrity, upregulation of human leukocyte antigen molecules, induction of 
inflammatory cytokines, expression of leukocyte adhesion molecules, and a change from an 
antithrombotic to prothrombotic phenotype (Hunt and Jurd, 1998).  Endothelial cells are 
critical components of the vasculature as they line the blood vessels and are involved in 
hemostatic balance, vasomotor tone, blood cell trafficking, permeability, and immunity.  In 
addition, endothelial cells have a critical role in the coagulation system and are able to 
express procoagulant factors, anti-coagulant factors, and fibrinolytic proteins (Aird, 2007).   
Endothelial cells are key participants in venous and arterial thrombosis formation, 
which upon rupture may lead to strokes or myocardial infarction.  Air particle pollution is 
associated with CV and cerebrovascular events that are triggered by thrombus formation.  
Recent studies have illustrated that PM exposure can increase the risk of deep vein 
thrombosis (Baccarelli et al., 2008), myocardial infarctions (Murakami and Ono, 2006), and 
fatal strokes (Kettunen et al., 2007).  Endothelial activation could link inhaled PM to vascular 
dysfunction, which make endothelial cells an excellent cellular model to use for studying the 
mechanisms leading to CV adverse effects due to air particle pollution exposure (Figure 1.2). 
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Figure 1.2 
 
Figure 1.2  Schematic diagram illustrating how exposure to soluble UF can lead to 
adverse CV events. 
Toxicological exposure, vessel wall damage, or pathological activation of cells of the 
vasculature, including endothelial cells, can initiate the coagulation cascade.  The coagulation 
cascade is traditionally divided into the extrinsic and intrinsic pathways that converge into a 
common pathway.  Altered expression and activity of tissue factor (TF) initiates the extrinsic 
pathway of the coagulation cascade, which is proposed to be the primary initiator of the 
coagulation cascade in vivo, whereas the intrinsic pathway is thought to be involved in the 
amplification of the coagulation cascade and recruitment of platelets to the rapidly forming 
thrombus (Mackman et al., 2007).  TF forms a complex with FVIIa to activate FX into FXa.  
FXa forms the prothrombinase complex with FVa, which activates prothrombin to thrombin.  
Thrombin is involved in several aspects of the coagulation cascade including activation of 
cofactors FV, FXI, and FVIII of the intrinsic pathway that leads to amplification of 
coagulation, activation of platelets that are necessary components of haemostatic plug, and 
activation of fibrinogen into fibrin that is the basis of the fibrin thrombus (Figure 1.3) (Ott, 
2011). 
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Figure 1.3 
 
Figure 1.3  Schematic diagram illustrating the extrinsic pathway of the coagulation 
cascade. 
One important area for research is understanding how air pollution affects specific 
components of the coagulation cascade such as thrombin generation and fibrin thrombus 
formation.  There are several tools available to assess the functional coagulation balance of 
endothelial cells following pathological injury or toxicological exposures.  The Calibrated 
Automated Thrombography (CAT) assay was developed to measure thrombin generation for 
potential use in clinical settings as a global test to assess hyper- and hypocoagulability in 
blood (Campo et al., 2012; Hemker et al., 2002; Luddington and Baglin, 2004).  In recent 
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studies, this assay has been utilized to determine the effects of air pollution on thrombin 
generation in animal and human models (Emmerechts et al., 2012; Kilinc et al., 2011; Rudez 
et al., 2009).  For example, Emmerechts et al. demonstrated that elevated levels of coarse PM 
shortened the lag time of thrombin generation in microparticle-rich plasma obtained from 
diabetic individuals exposed to ambient air pollution (Emmerechts et al., 2012).  In addition, 
fibrin thrombus formation can be measured as a way to assess the functional coagulation 
balance following exposure to air pollution.  For instance, Metassan et al. have shown 
increased polymerization of purified human fibrinogen in the presence of UF PM (Metassan 
et al., 2010).   
 Activation and upregulation of TF is an important initiating step in thrombin and 
fibrin formation, and TF is implicated in the effects of air pollution on the coagulation 
system.  Under normal physiological conditions, vascular cells that are in contact with blood 
typically do not express TF, so the extrinsic coagulation pathway is quiescent.  However, 
under pathological conditions that cause endothelial activation, TF can be presented to the 
circulation by a variety of vascular cells where it can initiate blood coagulation.  TF 
expression is generally suppressed in endothelial cells but can be induced by inflammation 
(Levi and van der Poll, 2005), endotoxin (Colucci et al., 1983), and exposure to air pollution 
(Karoly et al., 2007; Sun et al., 2008) in vitro.  In addition, TF can be introduced to the 
circulation via vascular cell-derived microparticles, which are vesicles that are shed from the 
plasma membranes of cells in response to injury, apoptosis, or activation (Morel et al., 2006).  
TF-bearing microparticles have been shown to be released from several types of vascular 
cells including vascular smooth muscle cells, leukocytes, platelets and endothelial cells 
(VanWijk et al., 2003).  Microparticles released from endothelial cells are an additional 
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indication of endothelial cell activation and are known to play a role in thrombosis and 
atherosclerosis (Chironi et al., 2009).   
 There are several checks and balances throughout the coagulation cascade to prevent 
pathological thrombus formation from occurring.  For instance, several anticoagulant 
proteins such as tissue factor pathway inhibitor (TFPI), thrombomodulin, and endothelial 
protein C receptor (EPCR) play pivotal roles in counteracting the increased expression or 
activation of procoagulant proteins that arise from cellular injury or pathological conditions.  
TFPI is the primary inhibitor of TF-initiated coagulation by binding and inhibiting the 
TF/FVIIa complex (Figure 1.3) (Bajaj et al., 2001).  This inhibition prevents initiation of the 
extrinsic coagulation cascade until enough TF/FVIIa complex is formed to pass a threshold 
that would exceed the inhibitory potential of TFPI (Crawley and Lane, 2008).  
Thrombomodulin is a transmembrane protein present on endothelial cells that binds to 
thrombin with high affinity.  This results in activation of protein C (PC) (Anastasiou et al., 
2012) and loss of thrombin’s procoagulant ability by reducing its ability to cleave fibrinogen, 
activate FV, and trigger platelet activation (Figure 1.3) (Van de Wouwer et al., 2004).  EPCR 
is a transmembrane protein constitutively expressed on the surface of endothelial cells that 
binds FVIIa, which prevents the formation of the TF/FVIIa complex (Figure 1.3), and binds 
PC (Navarro et al., 2011).  The binding of PC to EPCR enhances the rate of PC activation by 
the thrombomodulin-thrombin complex by roughly 20-fold (Stearns-Kurosawa et al., 1996).  
Upon activation, activated PC (APC) inactivates the procoagulant proteins FVIIIa and FVa 
by cleaving peptide bonds, which results in the downregulation of thrombin generation (Van 
de Wouwer et al., 2004).  APC also inhibits PAI-1 which promotes fibrinolysis, reduces 
inflammation by attenuating activation of the transcription factor NF-κB, and blocks p53-
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mediated apoptosis (Anastasiou et al., 2012; Cheng et al., 2003).  The balance of these 
factors is critical, and enhanced procoagulant activity or inhibition of anticoagulant activity 
could indicate an activated endothelial cell phenotype, resulting in a prothrombotic state 
(Gilmour et al., 2005).    
There is strong cross-talk between the coagulation and inflammatory pathways that 
involves inflammatory mediators activating the coagulation cascade or suppressing 
anticoagulant proteins, and coagulation proteins inducing inflammation (Levi et al., 2004a).  
Inflammation predominately induces coagulation by activating TF and the extrinsic 
coagulation pathway leading to thrombin generation (van der Poll et al., 2011).  For example, 
proinflammatory cytokines, namely TNF-α and IL-1β, have been shown to induce TF 
expression and increase procoagulant activity in endothelial cells (Dinarello, 1991).  
Inflammation is also capable of impairing several anticoagulant pathways (Levi and van der 
Poll, 2005).  Proinflammatory cytokines have been shown to down-regulate the anticoagulant 
protein TM, which in turn prevents the formation of the thrombomodulin-thrombin complex 
that is necessary for the activation of PC (Nawroth and Stern, 1986).  Inflammation also 
reduces levels of the anticoagulant protein antithrombin, the main inhibitor of thrombin and 
FXa (Levi et al., 2004a), and down-regulates TFPI, the main inhibitor of TF (Delvaeye and 
Conway, 2009).  
Similarly, procoagulant mediators are well known to induce inflammatory responses.  
For instance, thrombin activated platelets have been shown to release the CD40 ligand, 
which leads to upregulation of inflammatory cytokines and increased expression of cell 
adhesion molecules in endothelial cells (Henn et al., 1998).  Furthermore, TF has been 
thoroughly documented as having a critical role in linking these two pathways (Levi and van 
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der Poll, 2005).  The TF/FVIIa complex can bind protease activated receptors (PARs), 
leading to the induction of cell signaling pathways that result in increased expression of 
proinflammatory cytokines (Cunningham et al., 1999).  Thrombin and FXa are also capable 
of binding to PARs and activating these signaling pathways (Levi et al., 2004b).  In addition, 
it was shown in baboons that inhibition of TF activity prevents inflammation-induced 
thrombin generation (Taylor et al., 1991) and genetically altered mice with low levels of TF 
had attenuated levels of proinflammatory cytokines following exposure to endotoxin 
(Pawlinski et al., 2004). 
 Aberrant induction of TF has been associated with multiple CV disease pathologies 
including venous thrombosis, atherosclerosis, and diabetes (Lwaleed et al., 2007; Manly et 
al., 2010). TF can be induced by a variety of stimuli that primarily activate phospholipase C, 
resulting in a cascade of signaling events that eventually cumulate in the upregulation of TF 
expression (Herkert and Gorlach, 2002).  TF is also a redox-regulated protein, and TF gene 
expression and protein levels have been shown to be modulated by ROS in vascular cells 
(Herkert et al., 2004).  Additionally, TF mRNA expression is attenuated in the presence of 
antioxidants following exposure to ionizing radiation and inflammatory cytokines, further 
illustrating the critical role ROS plays in TF regulation (Szotowski et al., 2007).  ROS is 
thought to induce TF through activation of transcription factors resulting in induction of TF 
mRNA, and the TF gene in primary endothelial cells has been shown to contain binding sites 
for the redox-sensitive transcription factors NF-κB, AP-1, and SP1 (Herkert and Gorlach, 
2002; Moll et al., 1995).   
ROS are produced in response to a variety of both physiological and pathological 
stimuli (Frey et al., 2008; Sprague and Khalil, 2009).  The initial step in ROS generation is 
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production of the superoxide anion (·O2) from molecular oxygen (O2).  Superoxide is 
transformed into a subsequent ROS, hydrogen peroxide (H2O2), a reaction that is facilitated 
by the enzyme superoxide dismutase (SOD) (Mills et al., 2007).  H2O2 can then be cleaved by 
catalase into water and oxygen.  In the presence of transition metals, H2O2 can also be 
converted into the very reactive hydroxyl radical (·OH) (Droge, 2002) (Figure 1.4).  
Figure 1.4 
 
Figure 1.4  Pathways of ROS production. 
Cellular generation of ROS is important physiologically because these molecules can 
be used as both intra- and intercellular signaling molecules (D'Autreaux and Toledano, 
2007).  Superoxide is relatively unstable in aqueous conditions and is rapidly transformed 
into H2O2 either by SOD or spontaneously, so it is generally thought that signaling events 
occur through the H2O2 molecule (Li and Shah, 2004).  H2O2 is capable of oxidizing cysteine 
residues in proteins to cysteine sulfenic acid or disulfide, which can lead to protein 
phosphorylation and initiation of signaling cascades (Rhee et al., 2000).  Additionally, H2O2 
has been shown to activate transcription factors, such as NF-κB (Schmidt et al., 1995), AP-1 
(Karin and Shaulian, 2001) and p53 (Thomas et al., 2006) , leading to induction of redox-
sensitive genes.     
H2O2 is a membrane soluble molecule is detectable both extra- and intracellularly 
(Rhee et al., 2010).  Extracellular H2O2 release can be measured using the impermeant 
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Amplex Red reagent (N-acetyl-3,7-dihydroxyphenoxazine) (Li et al., 2006).  H2O2 reacts 
with Amplex Red in the presence of horseradish peroxidase (HRP) to produce resorufin, a 
highly fluorescent molecule that can be measured using a fluorescent plate reader (Figure 
1.5) (Rhee et al., 2010).  The Amplex Red reagent is specific for H2O2 and is highly sensitive 
with the ability to detect 5pmol of H2O2 per 100 µL sample (Bartosz, 2006).  The Amplex 
Red reagent is not membrane permeable, so it is used to detect both extracellular H2O2 that 
was made on the plasma membrane of the cell and intracellular H2O2 that diffused through 
the cellular membrane into the extracellular space.  Intracellular H2O2 can be measured by 
Peroxy Green 1 (PG1), a small-molecule fluorophore that is membrane soluble (Miller et al., 
2007).  PG1 is a boronate-based probe that fluoresces upon removal of the boronate group by 
H2O2 (Figure 1.5) (Miller et al., 2007).  PG1 is highly specific for intracellular H2O2 and is 
able to detect physiologically relevant levels of H2O2 in live, individual cells during real time 
using confocal microscopy (Cheng et al., 2010). 
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Figure 1.5 
 
Figure 1.5  Schematic diagram illustrating activation of the Amplex Red reagent and 
PG1 by H2O2.  Images were modified from Wentworth et al. and Miller et al. (Miller et 
al., 2007; Wentworth et al., 2000). 
  ROS concentrations are tightly controlled by enzymatic (i.e. catalase, SODs, heme 
oxygenase (HO), thioredoxin) and non-enzymatic antioxidants (i.e. uric acid, glutathione, 
vitamins A, C, and E) (Li and Shah, 2004).  However, under pathophysiological conditions, 
ROS can be produced at an elevated rate, overwhelming these antioxidant systems and 
resulting in oxidative stress that leads to cellular damage.  For instance, elevated levels of 
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H2O2 have been shown to induce cellular injury by causing damage to key cellular molecules 
such as DNA (Imlay et al., 1988), proteins (Knock and Ward, 2011), and lipids (Kellogg and 
Fridovich, 1975).  Furthermore, elevated levels of ROS are implicated in the pathogenesis 
and progression of several CV diseases including atherosclerosis, hypertension, and diabetes 
(Madamanchi et al., 2005).        
Endothelial cells can generate ROS in a variety of enzymatic and non-enzymatic 
ways, such as the mitochondrial electron transport chain, xanthine oxidases, and NADPH 
oxidase (NOX) enzymes (Droge, 2002; Li and Shah, 2004).  In addition, transition metals, 
such as iron, copper, and chromium are capable of undergoing redox cycling and producing 
intracellular ROS through Fenton reactions (Jomova and Valko, 2011).  Of these potential 
sources, NOX enzymes are proposed as the key generator of ROS production in the 
vasculature (Babior, 2000; Mohazzab et al., 1994).   
NADPH oxidases are a family of enzymes comprised of 7 major members, NOX1-5 
and Duox1-2 (Frey et al., 2008).  NOX-2 was the first to be characterized, where it was 
discovered on the plasma membrane of phagocytic cells and shown to produce a respiratory 
burst of oxidants for microbial defense (Babior, 1984).  Since that discovery, the NOX 
family of enzymes have been reported in an assortment of non-phagocytic cells including 
fibroblasts, vascular smooth muscle cells, and endothelial cells among others (Brown and 
Griendling, 2009). Endothelial cells express mainly the NOX-2 and NOX-4 isoforms (Li and 
Shah, 2004), but expression levels of the NOX isoforms varies among different endothelial 
cell types (Guzik et al., 2004).    
NOX isoforms are differentially expressed and regulated depending on the type of 
tissue in which they are located (Altenhofer et al., 2012).  Furthermore, NOX enzymes can 
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be found in various subcellular locations and expression of these enzymes can dictate 
participation in distinct signaling pathways (Gough and Cotter, 2011).  For example, the 
intracellular distribution of NOX-4 is broad and has been shown to be variably located in the 
perinuclear space, endoplasmic reticulum, mitochondria, and nucleus of endothelial cells 
(Lassegue and Griendling, 2010; Lassegue et al., 2012) and has been reported to be involved 
in several cellular processes including vasodilation, cell migration, and proliferation 
(Pendyala et al., 2009; Petry et al., 2006; Ray et al., 2011). 
Most NOX isoforms produce a basal level of ROS that can be further induced by an 
array of stimulants including cytokines, shear stress, G-protein coupled agonists, growth 
factors, and hypoxia (Griendling et al., 2000).  NOX-derived ROS function in basic 
physiological processes such as oxygen sensing, endothelial permeability, differentiation, and 
tissue development; however, pathological activation of NOX enzymes can lead to elevated 
levels of ROS, resulting in oxidative stress and cellular injury (Brown and Griendling, 2009; 
Frey et al., 2009).  For instance, ROS from NOX enzymes induced TF mRNA expression in 
vascular smooth muscle cells following agonist stimulation by thrombin or platelet-derived 
products from activated human platelets (Gorlach et al., 2000; Herkert et al., 2002).  
Furthermore, recent studies indicated that NOX-induced oxidative stress in endothelial cells 
plays an important role in the pathogenesis of CV disorders including hypertension, 
atherosclerosis, and diabetes (Madamanchi et al., 2005).  NOX enzymes are considered 
important therapeutic targets when trying to control overproduction of ROS (Schramm et al., 
2012) and inhibition of these enzymes is a potential approach to combat adverse CV health 
effects caused by air pollution exposure.     
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 Exposure to air pollution is strongly associated with CV morbidity and mortality but 
the mechanisms behind these associations are currently not known.  Endothelial cell 
activation, increased ROS production, and initiation of coagulation and inflammation are 
pathophysiological mechanisms that could link inhaled air pollutants to vascular events.  I 
hypothesize that exposure to soluble components of UF particles causes altered endothelial 
cell phenotype through activation of oxidant signaling that mediates procoagulant and 
proinflammatory responses resulting in a prothrombotic phenotype (Figure 1.6). 
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Figure 1.6 
 
Figure 1.6  Schematic diagram illustrating endothelial activation following exposure to 
soluble UF.  
  
 
CHAPTER 2   
 
SOLUBLE COMPONENTS OF ULTRAFINE PARTICLES STIMULATE H2O2 
PRODUCTION IN ENDOTHELIAL CELLS 
2.1 Introduction 
 A growing body of evidence shows a strong association between exposure to air 
pollution and cardiovascular (CV) morbidity and mortality.  Exposure to air pollution leads 
to increased hospitalizations for circulatory disorders (Poloniecki et al., 1997), accelerates the 
progression of atherosclerosis (Suwa et al., 2002), and increases the risk of myocardial 
infarctions (Peters et al., 2001).  In addition, elevated levels of air pollution are associated 
with increased risk of CV-related mortality (Pope et al., 2004).   The World Health 
Organization estimates that exposure to ambient air pollution causes several million 
premature deaths worldwide each year, with particulate matter (PM) exposure accounting for 
approximately 800,000 of those deaths (Anderson et al., 2012).   
PM is a major component of ambient air pollution and is derived from a variety of 
sources that are both natural and manufactured.  Classification of PM is determined by 
diameter of the particle: coarse particles (PM10) are 10 to 2.5 µm, fine particles (PM2.5) are 
2.5 to 0.1 µm, and ultrafine particles (UF; PM0.1) are <0.1 µm (Poschl, 2005).  PM is formed 
out of extremely small particles and liquid droplets with composition varying depending on 
geographical location, local pollution sources, time of day, season, and size of particle 
(Polichetti et al., 2009).  Coarse particles are typically derived from soil and sea salts and 
have been shown to contain endotoxin that induces proinflammatory responses (Brooks et al., 
2002), whereas fine and UF particles are predominantly derived from combustion sources 
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and are comprised of volatile organic compounds, polycyclic aromatic hydrocarbons, 
transition metals, and other constituents adsorbed on a carbonaceous core  (Polichetti et al., 
2009).  
 Epidemiological studies illustrated that exposure to elevated levels of coarse and fine 
PM induced adverse CV effects (Harrison and Yin, 2000; Polichetti et al., 2009).  The 
Environmental Protection Agency currently monitors and regulates PM10 and PM2.5, but 
increasing evidence suggests that UF particles are a key factor in the adverse CV effects due 
to air pollution exposure (Nel, 2005).  UF particles make up only a small portion of ambient 
PM by mass concentration; however, they constitute the majority of particle number per unit 
mass (Donaldson et al., 2001).  For example, at the same mass concentration, UF particles 
have a 6-fold increase in number concentration as compared to fine particles, resulting in 
significantly greater collective particle surface area (Stanek et al., 2011).   This high surface 
area-to-mass ratio allows for the adsorption of toxic substances such as organic compounds 
and transition metals (Sioutas et al., 2005).  In addition, the small diameter of UF particles 
makes them more likely to deposit in the alveolar region of the lung based on Brownian 
motion and diffusion transportation as opposed to coarse and fine particles that tend to 
deposit in the upper airways of the lung (Kreyling et al., 2004).  Because of their small size, 
UF particles remain longer in the lung following deposition since they are more likely to 
avoid being recognized and phagocytized by alveolar macrophages as compared to the larger 
coarse and fine particles (Gonzalez et al., 1996).  Even though UF particles may not leave the 
lung to directly mediate adverse CV effects (Brown et al., 2002; Mills et al., 2006; Nemmar 
et al., 2002); soluble components of UF particles (soluble UF) could cross from the lung into 
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the circulation and directly interact with cells of the vasculature such as endothelial cells 
(Wallenborn et al., 2007).   
Transition metals are a major component of the soluble fraction and may play an 
important role in the adverse CV effects associated with air pollution exposure (Costa and 
Dreher, 1997).  Transition metals can increase oxidative DNA damage in lymphocyte DNA 
and induce reactive oxygen species (ROS) production in endothelial cells, indicating that 
soluble components of PM are capable of inducing oxidative stress following exposure to air 
pollution (Montiel-Davalos et al., 2012; Sorensen et al., 2005). 
Elevated levels of ROS under pathological conditions have been linked to the 
development of several CV diseases (Madamanchi et al., 2005).  Endothelial cells can 
produce ROS in response to an array of both physiological and pathological stimuli from a 
variety of both enzymatic and non-enzymatic sources (Droge, 2002).  The major sources of 
ROS production in endothelial cells include the mitochondrial electron transport chain, 
xanthine oxidases, and NADPH oxidases (NOX), and of these, NOX enzymes are proposed 
to be the key generator of ROS production following exposure to toxic substances such as 
UF particles (Li and Shah, 2004; Mo et al., 2009).  Furthermore, NOX-induced oxidative 
stress in endothelial cells is implicated in the progression of various CV disorders including 
hypertension, atherosclerosis, and diabetes (Bengtsson et al., 2003)      
We hypothesize that UF particles cause ROS production in endothelial cells through 
activation of NOX enzymes by the soluble components.  There were several objectives to 
this study.  We set out to 1) determine the relevant size, fraction, and dose of PM to use 
throughout the project, 2) identify the primary cellular source for PM-induced ROS 
production, and 3) determine the components responsible for the adverse effects following 
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exposure.  We show here that exposure to non-cytotoxic doses of soluble UF increase ROS 
production in endothelial cells that is dependent on activation of NOX enzymes and 
transition metals.  
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2.2 Materials and Methods 
2.2.1 Reagents and Chemicals 
 EA.hy926 (EA cells), are an immortalized endothelial cell line derived by fusing 
human umbilical vein endothelial cells with A549 cells, a human lung adenocarcinoma 
epithelial cell line (Edgell et al., 1983).   EA cells were obtained from University of North 
Carolina’s Tissue Culture Facility (Chapel Hill, NC).  Dulbecco’s modified Eagle’s medium 
(DMEM)-high glucose, fetal bovine serum (FBS), and antibiotic-antimycotic (100X) were 
obtained from Gibco (Grand Island, NY). Human coronary artery endothelial cells 
(HCAEC), endothelial growth medium (EGM-2), and EGM-2 Bullet Kit were obtained from 
Lonza (Walkersville, MD).  All other chemicals and reagents were from Sigma Chemical 
Company (St. Louis, MO) unless otherwise stated. 
2.2.2  Cell Culture 
EA cells were cultured in DMEM-high glucose medium supplemented with 10% FBS 
and 1% antibiotic-antimycotic mix.  HCAEC were cultured in EGM-2 media supplemented 
with the EGM-2 Bullet Kit (2% FBS, 0.4% rhFGF-B, 0.1% gentamicin sulfate amphotericin-
B, 0.1% rhEGF, 0.1% heparin, 0.1% ascorbic acid, 0.1% R
3
-IGF-1, 0.1% VEGF, and 0.04% 
hydrocortisone).  HCAEC were obtained from two adult donors with no known history of 
CV disease.  Cells were grown to confluence and used between passages 5-8.   
2.2.3  Ultrafine Particles 
Coarse, fine, and UF particles were collected from February to May 2007 in Chapel 
Hill, NC as previously described (Becker et al., 2005).  UF particles were analyzed for 
chemical components by the Research Triangle Institute (Research Triangle Park, NC) and 
the composition of these particles is expressed relative to UF particle mass (ng/mg; Table 
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2.1).  The soluble fraction of these particles was acquired by suspending the particles in PBS 
at the desired concentration and centrifuging the resultant suspension for 30 minutes at 
20,000 x g.  The supernatant from the pelleted particles was collected and used as the soluble 
fraction.  The pellet was then re-suspended in the same volume of PBS and used as the 
insoluble fraction.   
2.2.4  Extracellular H2O2 Measurement using the Amplex Red Assay 
Extracellular H2O2 release was measured using the Amplex Red reagent (10-acetyl-
3,7-dihydroxyphenoxazine; Invitrogen, Carlsbad, CA), which reacts with H2O2 in the 
presence of horseradish peroxidase to produce resorufin, a highly fluorescent molecule.  EA 
cells and HCAEC were cultured on 12-well plates and exposed to coarse, fine, or UF PM (0, 
50, and 100 µg/mL).  Immediately following exposure, Amplex Red (150 μM) and HRP (0.8 
U/ml) were added, and plates were analyzed at 5 min intervals for 30 min on a Bioassay 
HTS7000 plate reader (Perkin-Elmer, Wellesley, MA) with HTSoft version 1.0 software (PE 
Applied Biosystems, Weiterstadt, Germany).  Excitation wavelength was 535 nm and 
emission fluorescence was 590 nm.  H2O2 was quantified by subtracting the baseline 
fluorescence from the final fluorescence, and normalizing these relative fluorescence units 
(RFU) to a standard curve of H2O2 (0-1 nm).  Following analysis, the endothelial cells were 
washed with PBS and cellular protein was collected with lysis buffer (20 mM Tris, 150 mM 
NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton-X-100, pH 7.4) containing 1:100 Protease 
Inhibitor Cocktail Set 1 (Calbiochem, La Jolla, CA).  Protein concentrations of cell lysates 
were measured using the Bio-Rad protein reagent (Bio-Rad, Richmond, CA) according to the 
manufacturer’s protocol.   
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2.2.5  Measurement of Cytotoxicity 
Cytotoxicity was determined by measuring supernatant lactate dehydrogenase (LDH) 
levels using the colorimetric CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega 
Corporation, Madison, WI) according to the manufacturer’s protocol.  EA cells and HCAEC 
were exposed to soluble UF (0, 10, 50, and 100 µg/mL) for 6 or 24 hours.  Supernatant from 
cells treated with saponin (0.5%) to disrupt the cellular membrane was a positive control for 
the assay.   
2.2.6  Statistical Analysis  
Statistical analysis was performed using commercially available software (GraphPad 
Prism, version 4.03 for Windows; GraphPad Software, San Diego, CA).  A one-way 
ANOVA analysis followed by Bonferroni’s post-hoc test was used to compare exposed cells 
to control cells.  A p-value < 0.05 was considered statistically significant. 
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2.3 Results 
2.3.1  Coarse, fine, and UF PM exposure increases extracellular H2O2 generation in 
endothelial cells 
 To determine the effect particle size has on PM-induced ROS production in 
endothelial cells, we exposed EA cells, an immortalized endothelial cell line, to coarse, fine, 
or UF particles (100 μg/mL).  Cells were exposed to the whole particle, and the soluble and 
insoluble fractions.  Extracellular H2O2 release was quantified over 30 min immediately 
following exposure using the Amplex Red assay.  We found that the whole particle of coarse, 
fine, and UF PM significantly (p<0.001) increased extracellular H2O2 production by 2.5-fold, 
5.4-fold, and 4-fold, respectively, compared to control cells (Fig. 2.1A-C).  The soluble 
fraction of UF particles induced a 3.7-fold increase (p<0.001) in extracellular H2O2 
production, which is roughly equivalent to that induced by the whole UF particle, whereas 
the insoluble fraction of UF particles did not induce a significant increase in H2O2 production 
in the EA cells.  While the soluble fractions of coarse and fine PM increased H2O2 
production as well, we demonstrate that the insoluble fraction of these particles also 
significantly (p<0.001 and p<0.05, respectively) increased extracellular H2O2 production.  
These data indicate that components of both the soluble and insoluble fractions of coarse and 
fine PM induce ROS production in EA cells, whereas only components of the soluble 
fraction of UF particles are responsible for the increased H2O2 release.  This experiment was 
repeated in human coronary artery endothelial cells (HCAEC) in order to assess the response 
in a primary cell model.  The studies illustrated that soluble UF induced a 15.8-fold increase 
(p<0.05) in extracellular H2O2 production in HCAEC, whereas the insoluble fraction did not 
cause a significant change (Fig. 2.1D).  This response in primary cells was substantially 
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augmented as compared to that in the EA cell line.  Given the responses, we selected the 
soluble fraction of UF particles for my project to evaluate endothelial cell responses to PM 
exposure. 
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Figure 2.1  
 
 
 
Figure 2.1  Exposure to soluble UF induces rapid H2O2 generation by EA and HCAEC.  
EA (A-C) and HCAEC (D) were exposed to the whole particle, soluble fraction, and 
insoluble fraction of coarse (A), fine (B), and UF (C-D) PM (100 µg/mL) and extracellular 
H2O2 release was measured using the Amplex Red reagent.  n = 3 independent experiments 
with samples in triplicate.  * = p<0.05, *** = p<0.001 compared to control. 
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2.3.2  Soluble UF exposure causes a dose- and time-dependent increase in extracellular H2O2 
generation in endothelial cells  
To ascertain the potential cytotoxicity over a range of soluble UF concentrations, 
LDH release was quantified following exposure to 10, 50, and 100 μg/mL soluble UF for 6 
and 24 hrs.  Soluble UF did not induce cytotoxicity in the EA (Fig. 2.2A) or HCAEC (Fig. 
2.2B).  In addition, extracellular H2O2 production by both the EA and HCAEC increased in a 
dose- and time-dependent manner following exposure to soluble UF (50 and 100 μg/mL) 
(Fig. 2.2C-F).  These data indicate that exposure to soluble UF increases extracellular H2O2 
release in a concentration- and time-dependent manner at doses that are non-cytotoxic to 
endothelial cells.  For a majority of the remaining experiments in this project, we will expose 
the endothelial cells to the intermediate (50 μg/mL) or high (100 μg/mL) dose of soluble UF.         
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Figure 2.2   
 
Figure 2.2  Non-cytotoxic doses of soluble UF increase H2O2 production in a dose- and 
time-dependent manner in EA and HCAEC.  EA (A) and HCAEC (B) were exposed to 
soluble UF (0, 10, 50, and 100 µg/mL) or the detergent saponin (0.5%) as the positive control 
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for 6 or 24 hrs.  LDH release was measured as a marker of cytotoxicity using the CytoTox 96 
Non-Radioactive Cytotoxicity Assay.   n = 3 independent experiments with samples in 
triplicate.  EA (C, E) and HCAEC (D, F) were exposed to soluble UF (0, 50, and 100 µg/mL) 
and the Amplex Red reagent was used to measure the dose response (C-D) and time response 
(E-F) of extracellular H2O2 release.  n = 3 independent experiments with samples in 
duplicate.  * = p<0.05, *** = p<0.001 compared to control. 
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2.3.3  Soluble UF-induced ROS production is from NOX enzymes 
  To determine the cellular source of soluble-UF induced H2O2 production, we 
measured extracellular H2O2 production by EA cells in the presence of chemical inhibitors of 
several key sources of ROS production in endothelial cells.  Soluble UF-induced 
extracellular H2O2 release was not inhibited by allopurinol, a xanthine oxidase inhibitor (Fig. 
2.3A) or inhibitors targeting the mitochondrial respiratory chain complex I (Fig. 2.3B) and 
IV (Fig. 2.3C).  However, DPI, a NOX inhibitor, reduced extracellular H2O2 production in 
EA cells exposed to 50 and 100 μg/mL soluble UF by 57% and 59% respectively (Fig. 2.3D).  
These experiments were repeated in primary endothelial cells.  Pretreatment with DPI 
significantly (p<0.05) attenuated extracellular H2O2 production in HCAEC exposed to 50 and 
100 μg/mL soluble UF by 54% and 38% respectively (Fig. 2.3E).  These data implicate NOX 
enzymes as a major source of H2O2 production in endothelial cells following exposure to 
soluble UF.   
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Figure 2.3 
 
Figure 2.3  Soluble UF-induced ROS production is dependent on NOX enzymes.  
Extracellular H2O2 was measured using the Amplex Red reagent in EA (A-D) and HCAEC 
(E) pretreated with the xanthine oxidase inhibitor allopurinol (A, 20 µM), the mitochondrial 
respiratory chain complex I inhibitor rotenone (B, 10 µM), the mitochondrial respiratory 
chain complex IV inhibitor KCN (C, 10 µM), or the NOX inhibitor DPI (D-E, 50 µM) for 30 
minutes followed by exposure to 50 or 100 μg/mL soluble UF.  n = 3 separate experiments 
with samples in duplicate.  * = p<0.05, ** = p<0.01 *** = p<0.001  
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2.3.4  Soluble UF-induced extracellular H2O2 generation in HCAEC is dependent on 
transition metals 
 We next wanted to measure the UF particle-associated components to provide 
information on compounds present in the soluble fraction that could lead to increased ROS 
production.  The UF particles were analyzed at the Research Triangle Institute and 
components are expressed relative to UF particle mass (ng/mg; Table 2.1).  The measured 
levels of these elements and ions are comparable to those found in Chapel Hill UF particles 
previously collected and analyzed in 2001 and 2002 (Becker et al., 2005).  Transition metals, 
such as chromium, copper, iron, nickel, vanadium, and zinc, were present in the UF particles.  
To determine if these transition metals have a role inducing extracellular H2O2 production, 
we measured the extracellular H2O2 release from HCAEC following exposure to 50 μg/mL 
soluble UF that had been pretreated with the metal chelator deferoxamine for 15 min.  
Pretreatment with deferoxamine (100 µM) reduced extracellular H2O2 production in soluble 
UF-exposed HCAEC by 45% (p<0.001; Fig. 2.4).  These data indicate that transition metals 
play a partial role in the adverse effects induced in endothelial cells following exposure to 
soluble UF and suggest that other soluble components are also involved.   
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Table 2.1 
Component ng/mg   Component ng/mg 
Aluminum 855.0   Nitrate 44100.0 
Arsenic 55.8   Nitrite 579.0 
Bromide 1824.0   Selenium 76.5 
Chromium 12.3   Silicon 3480.0 
Copper 108.0   Sulfur 99300.0 
Iron 624.0   Titanium 21.5 
Lead 79.5   Vanadium 57.0 
Nickel 34.2   Zinc 735.0 
 
Table 2.1 Components of UF PM (ng/mg) collected in Chapel Hill, NC from February 
to May 2007. 
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Figure 2.4 
 
Figure 2.4  Soluble UF-induced H2O2 production is dependent on transition metals.  
HCAEC were exposed to soluble UF (0 or 50µg/mL) that were pretreated with the metal 
chelator deferoxamine (100 µM) for 15 min.  Extracellular H2O2 release was measured using 
the Amplex Red reagent. n = 3 independent experiments with samples in triplicate.  *** = 
p<0.001 compared to control. 
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2.4 Discussion 
Increasing evidence suggests a strong association between exposure to air pollution 
and CV morbidity and mortality (Brook, 2008; Polichetti et al., 2009; Pope et al., 2004); 
however, further investigation needs to be conducted on the adverse vascular effects 
associated with exposure to components of PM.  Here we report that exposure to non-
cytotoxic doses of soluble components of UF particles increase extracellular H2O2 release in 
immortalized and primary endothelial cells.  We further show that this induced H2O2 
production is dependent on NOX enzymes and transition metals.  These novel findings 
suggest that particle-induced ROS production in endothelial cells is a plausible mechanism 
for adverse CV events associated with exposure to air pollution.   
 Our results add to a growing body of evidence linking PM to the adverse CV effects 
associated with air pollution exposure.  We showed that exposure to coarse, fine, and UF PM 
increased extracellular H2O2 production in endothelial cells.  This finding supports previous 
studies showing that the different sized fractions of PM induce ROS production in bronchial 
epithelial cells and alveolar macrophages (Becker et al., 2005).  We also demonstrated that 
the soluble and insoluble fraction of coarse and fine PM induced extracellular H2O2 
production, whereas only the soluble fraction of UF particles increased H2O2 release.  This 
finding is important because it further supports the concept that the water soluble 
components of UF particles, which are capable of translocating to the vasculature, are 
responsible for the adverse CV effects associated with PM exposure.  It is not certain if 
whole PM particles can translocate from the lung to the vasculature (Mills et al., 2006; 
Nemmar et al., 2002).  Since UF particles are most capable of depositing in the heavily 
vascularized alveoli (Kreyling et al., 2004) and the soluble fraction of PM is more likely to 
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traverse the alveolar-capillary barrier to enter the vasculature (Wallenborn et al., 2007), we 
designed our experiments to evaluate endothelial cell responses to PM exposure using the 
soluble fraction of UF particles.   
Elevated levels of ROS have been shown to induce cellular injury by causing damage 
to key cellular molecules and have been implicated in the pathogenesis and progression of 
several CV diseases (Imlay et al., 1988; Kellogg and Fridovich, 1975; Knock and Ward, 
2011; Madamanchi et al., 2005).  We show here that exposure to soluble UF induces 
immediate ROS production in endothelial cells; suggesting vascular oxidative stress may 
occur following air pollution exposure.  While there are several major sources of ROS 
production in endothelial cells, a recent study has shown that mouse pulmonary 
microvascular endothelial cells exposed to whole UF particles induced ROS production by 
NOX enzymes (Mo et al., 2009).  Our data extend this finding by illustrating that NOX 
enzymes are the likely source of H2O2 production following exposure to water-soluble 
components of UF particles in human endothelial cells.  Inhibition of NOX enzymes is an 
emerging strategy to combat oxidative stress-mediated diseases (Jaquet et al., 2009) and our 
data further illustrate the prospect of targeting these enzymes when trying to combat adverse 
CV effects due to air pollution exposure.    
Transition metals are thought to play an important role in the adverse health effects 
associated with air pollution exposure (Costa and Dreher, 1997).  Several studies involving 
air pollution samples collected when a steel mill in Utah Valley was open (1986), closed 
(1987), and reopened (1988) demonstrated that metals associated with PM induce adverse 
pulmonary effects (Stanek et al., 2011).  Extracts from 1986 and 1988 contained the highest 
levels of metals and were shown to induce pulmonary injury and inflammation in rats (Dye et 
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al., 2001), increase pulmonary inflammation in healthy human volunteers (Ghio and Devlin, 
2001), and increase rates of respiratory related hospital admissions (Pope, 1989).  In addition, 
in vitro studies have shown that transition metals induce inflammatory responses and 
increase ROS production in pulmonary and vascular cells (Gojova et al., 2007; Montiel-
Davalos et al., 2012; Shafer et al., 2010).  For instance, Shafer et al. demonstrated that 
pretreatment with metal chelators attenuated particle-induced ROS production in rat alveolar 
macrophages, indicating that transition metals in the water-soluble fraction of coarse and fine 
PM are responsible for the increased ROS production (Shafer et al., 2010).  Our results 
extend these observations by illustrating that transition metals associated with the soluble 
fraction of UF particles cause adverse vascular effects by inducing H2O2 production in 
endothelial cells.   
There are potential limitations to this study.  We are not certain of the PM 
concentration HCAEC experience following an air pollution exposure.  However, individuals 
living in heavily polluted cities or exposed to natural disasters such as forest fires are capable 
of experiencing elevated levels of PM similar to the doses used in this study (Becker et al., 
2005).  In addition, the doses used in this study were not cytotoxic to the cells, indicating that 
the increased ROS production following exposure to soluble UF is due to endothelial 
activation rather than cellular death.  Endothelial activation could link inhaled air pollutants 
to vascular events and have been shown to contribute to the pathogenesis of a variety of CV 
diseases (Szmitko et al., 2003).  We used EA cells and HCAEC as our cellular models for 
studying CV adverse effects due to air pollution exposure.  EA cells are an immortalized 
endothelial cell line derived by fusing human umbilical vein endothelial cells with A549 
cells, a human lung adenocarcinoma epithelial cell line (Edgell et al., 1983).  These cells 
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maintain most of the characteristics of endothelial cells, are fast growing, and ideal for 
establishing protocols, but the effects produced in these cells may not fully represent effects 
in primary endothelial cells.  Therefore, we also used HCAEC as a primary endothelial 
cellular model.  Endothelial cells from the coronary artery are among the first vascular cells 
to receive fresh blood from the lung and will accordingly be exposed to high concentrations 
of any soluble components that cross into the circulation from the alveoli. 
 In summary, we have shown that exposure to soluble UF induces production of 
extracellular H2O2 from NOX enzymes in endothelial cells.  This increase in ROS production 
is dependent upon transition metals located in the soluble fraction.  These novel findings 
support the assertion that particle-induced ROS is a plausible mechanism by which PM 
exposure induces adverse CV health effects. 
  
 
 
 
CHAPTER 3   
 
SOLUBLE COMPONENTS OF ULTRAFINE PARTICLES INDUCE 
ENDOTHELIAL PROCOAGULANT ACTIVITY THROUGH OXIDANT 
SIGNALING 
3.1 Introduction 
Epidemiological evidence reveals a strong association between exposure to air 
pollution and increased cardiovascular (CV) morbidity and mortality (Baccarelli et al., 2008; 
Calderon-Garciduenas et al., 2008; Pope et al., 2004).  One of the major components of air 
pollution is particulate matter (PM), which is categorized based on the diameter of the 
particles: coarse (10-2.5 μm), fine (2.5-0.1 μm), and ultrafine (UF; <0.1 μm).  The United 
States Environmental Protection Agency currently monitors and regulates coarse and fine 
PM, but increasing evidence suggests that UF particles, which are not currently regulated, are 
particularly important mediators of CV effects of air pollution (Nel, 2005).  Although UF 
particles comprise only a small portion of ambient PM by mass concentration, they constitute 
the majority of particles by number and have a significantly large surface area-to-mass ratio 
(Donaldson et al., 2001).  In addition, UF particles can deposit in the alveolar region of the 
lung because of their small diameter (Kreyling et al., 2004).  Because these particles are not 
as well recognized or phagocytized by alveolar macrophages (Gonzalez et al., 1996), they 
may remain longer in the lung, which increases the probability of causing adverse effects.  
Furthermore, soluble components of UF particles (soluble UF) could traverse the alveolar-
capillary barrier to enter the vasculature (Wallenborn et al., 2007).  These soluble 
components, which include transition metals, induce oxidative stress and procoagulant 
44 
 
activity in animal and human models (Araujo et al., 2008; Sorensen et al., 2005); however, 
the mechanisms behind these responses have not been delineated.   
A causal link between vascular effects of PM exposure and procoagulant responses is 
suggested by the finding that exposure to soluble UF increases tissue factor (TF) mRNA 
expression in human pulmonary artery endothelial cells (Karoly et al., 2007).  Under normal 
physiological conditions, TF is not highly expressed on endothelial cells, but surface 
expression of TF can be induced by a variety of stimuli including fibrin, endotoxin, and the 
proinflammatory cytokines TNF-α and IL-1β (Colucci et al., 1983; Contrino et al., 1997; 
Dinarello, 1991; Levi and van der Poll, 2005).  Altered expression and activity of TF is of 
particular interest because, once activated, this membrane-bound protein is the primary 
initiator of the extrinsic coagulation pathway resulting in thrombin generation and fibrin 
thrombus formation (Lwaleed et al., 2007).  Elevated levels of TF have been associated with 
adverse CV effects including venous thrombosis and atherosclerosis (Lwaleed et al., 2007; 
Manly et al., 2010).   
TF is a redox-regulated protein, and TF gene expression and protein levels can be 
modulated by ROS in vascular cells (Herkert and Gorlach, 2002).  Endothelial cells produce 
ROS in response to a variety of physiological and pathological stimuli, including exposure to 
UF particles (Mo et al., 2009).  One major cellular source of ROS production is the NADPH 
oxidase (NOX) family of enzymes (Li and Shah, 2004).  Endothelial cells express mainly the 
NOX-2 and NOX-4 isoforms but expression levels of the NOX family members vary among 
different endothelial cell types (Guzik et al., 2004).   Most NOX homologs produce basal 
levels of ROS that can be further induced by a variety of agonists (Griendling et al., 2000).  
ROS can regulate procoagulant activity; for example ROS from NOX enzymes alters TF 
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expression in platelet-activated vascular smooth muscle cells (Gorlach et al., 2000).  In 
addition, NOX-induced oxidative stress in endothelial cells plays an important role in the 
pathogenesis of CV disorders (Madamanchi et al., 2005), perhaps through these and other 
mechanisms. 
 The objective of our study was to determine if soluble components of UF particles 
induced procoagulant responses in human endothelial cells, and to define the mechanisms 
behind these effects.  We show here that endothelial cells exposed to soluble UF induce 
faster onset of thrombin generation and fibrin thrombus formation via TF upregulation that is 
dependent upon increased ROS production and the NOX-4 enzyme. 
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3.2 Materials and Methods 
3.2.1  Reagents and Chemicals 
Human coronary artery endothelial cells (HCAEC), endothelial growth medium 
(EGM-2), and EGM-2 Bullet Kit were obtained from Lonza (Walkersville, MD).  All other 
chemicals and reagents were from Sigma Chemical Company (St. Louis, MO) unless 
otherwise stated.  
3.2.2  Cell Culture 
HCAEC were cultured in EGM-2 media supplemented with the EGM-2 Bullet Kit 
(2% FBS, 0.4% rhFGF-B, 0.1% gentamicin sulfate amphotericin-B, 0.1% rhEGF, 0.1% 
heparin, 0.1% ascorbic acid, 0.1% R
3
-IGF-1, 0.1% VEGF, and 0.04% hydrocortisone).  
HCAEC were obtained from two donors with no known history of CV disease.  Cells were 
grown to confluence and used between passages 5-8. 
3.2.3  Ultrafine Particles 
UF particles collected from February to May 2007 in Chapel Hill, NC were analyzed 
for chemical components by the Research Triangle Institute (Research Triangle Park, NC) as 
previously described (Becker et al., 2005).  The composition of these particles is expressed 
relative to UF particle mass (ng/mg) (Table 2.1).  The measured levels of these elements and 
ions are comparable to those found in Chapel Hill UF particles previously collected and 
analyzed in 2001 and 2002 (Becker et al., 2005).  The soluble fraction of these UF particles 
was acquired by suspending the particles in PBS at the desired concentration and 
centrifuging the resultant suspension for 30 minutes at 20,000 x g.  The supernatant from the 
pelleted particles was collected and used as the soluble fraction.   
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3.2.4  Measurement of Cytotoxicity 
Cytotoxicity was determined by measuring supernatant LDH levels using the 
colorimetric CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega Corporation, 
Madison, WI) according to the manufacturer’s protocol.  Supernatant from cells treated with 
saponin (0.5%) to disrupt the cellular membrane was a positive control for the assay.   
3.2.5  Calibrated Automated Thrombography (CAT) Assay 
Platelet-free plasma (PFP) from healthy donors was prepared as previously described 
(Machlus et al., 2009).  Cellular procoagulant activity was measured as previously described 
with minor alterations (Campbell et al., 2009).  Briefly, HCAEC were cultured on 96-well 
plates and exposed to soluble UF (0, 10, 50, and 100 µg/mL) for 6 hrs.  Following exposure, 
cells and PFP were incubated with either an inhibitory anti-human TF monoclonal inhibitory 
antibody or control mouse IgG for 15 min at 37°C.  PFP with antibodies, MP reagent 
containing phospholipids (4 µM; 60% phosphatidylcholine/20% 
phosphatidylethanolamine/20% phosphatidylserine; Diagnostica Stago, Parsippany, NJ), and 
a fluorogenic thrombin substrate (Z-Gly-Gly-Arg-AMC; Diagnostica Stago, Parsippany, NJ) 
were then added to the cells as previously described (Machlus et al., 2009).  Reactions were 
calibrated against wells containing a thrombin calibrator (α2-macroglobulin/thrombin 
complex; Diagnostica Stago, Parsippany, NJ).  Thrombin generation was measured using a 
Fluoroskan Ascent® fluorometer (ThermoLabsystem, Helsinki, Finland).  Thrombinoscope 
software version 3.0.0.29 (Thrombinoscope BV, Maastricht, Netherlands) was used to 
calculate lag time (first time point after the thrombin concentration exceeds one-sixth peak 
height), peak (greatest amount of thrombin generation at a single point in time), time to peak 
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(time to reach the maximum peak height), and endogenous thrombin potential (ETP; total 
amount of thrombin generated during the test). 
3.2.6  Turbidity Assay 
HCAEC were cultured and exposed to soluble UF as described above.  Recalcified 
(20mM, final) PFP and phospholipids (125 μM, 41% phosphatidylcholine/44% 
phosphatidylethanolamine/15% phosphatidylserine; Avanti Polar Lipids, Alabaster, AL) 
were added to the cells at a final volume of 100 μl to initiate thrombus formation (Gray et al., 
2011). Fibrin thrombus formation was analyzed by an increase in turbidity at 405 nm with a 
SpectraMax 340PC plate reader (Molecular Devices, Sunnyvale, CA).  Softmax® Pro 
Software version 1.21 (Molecular Devices, Sunnyvale, CA) was used to calculate thrombus 
formation onset (time to reach inflection point before turbidity increase) and Vmax (slope of 
the line fitted to maximum rate of turbidity increase using 10 points to determine the line).   
3.2.7  Real-Time Quantitative PCR 
Relative gene expression in HCAEC was obtained using quantitative RT-PCR.  Total 
RNA was isolated from HCAEC using an RNeasy kit (Qiagen, Valencia, CA) according to 
the manufacturer’s protocol.  RNA was quantified using a Nanodrop™ 1000 
Spectrophotometer (Thermo Scientific, Wilmington, DE).  cDNA was generated as 
previously described (Karoly et al., 2007).  Oligonucleotide primer pairs and fluorescent 
probes for β-actin (forward, 5’-CCTGGCACCCAGCACAAT-3’; reverse, 5’-
GCCGATCCACACGGAGTACT-3’; probe, 5’-
ATCAAGATCATTGCTCCTCCTGAGCGC-3’)  and TF (forward, 5’-
TTGGCACGGGTCTTCTCCTA-3’; reverse, 5’-CGAGGTTTGTCTCCAGGTAAGG-3’; 
and probe,  5’-AGAACCGGTGCTCTCCACATTCCCTG-3’) were designed using Primer 
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Express (Applied Biosystems) and obtained from Integrated DNA Technologies (Coralville, 
IA).  Thrombomodulin, endothelial protein C receptor (EPCR), tissue factor pathway 
inhibitor (TFPI), IL-1β, TNF-α, GAPDH, and NOX-4 primer pairs and fluorescent probe sets 
were obtained as Taqman pre-developed assay reagents from Applied Biosystems (Foster 
City, CA).  Quantitative fluorogenic amplification of cDNA was performed using the ABI 
Prism 7500 Sequence Detection System (Applied Biosystems, Foster City, CA), primer and 
probe sets of interest, and Taqman Universal PCR Master Mix (Applied Biosystems, Foster 
City, CA).  Standard curves generated from a serially diluted standard pool of cDNA 
prepared from cultured human endothelial cells exposed to 100 ng/mL TNF-α for 6 hrs were 
used to determine the relative abundance of mRNA levels.  The relative abundance of β-actin 
mRNA was used to normalize levels in genes of interest. 
3.2.8  Immunofluorescence 
 Confocal microscopy was used for detection of membrane-bound thrombomodulin.  
HCAEC were exposed to soluble UF (0 or 100 µg/mL) for 6hrs in a double well chamber 
slide with cover (Nalge Nunc International, Rochester, NY).  Following exposure, cells were 
fixed with methanol:acetone (1:3) for 20 min.  HCAEC were incubated overnight with anti-
thrombomodulin mouse anti-human antibody (Santa Cruz Biotechnology, Santa Cruz, CA) in 
1% BSA.  Alexa Fluor 594 goat anti-mouse IgG (Invitrogen, Carlsbad, CA) was used as a 
secondary antibody.  Prolong gold antifade reagent with DAPI (Invitrogen, Carlsbad, CA) 
was used to mount the slides.  Imaging was conducted using a Nikon Eclipse C1Si confocal 
microscope (Nikon Instruments Inc., Melville, NY, USA).      
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3.2.9  Extracellular H2O2 Measurement using the Amplex Red Assay 
Extracellular H2O2 release was measured using the Amplex Red reagent (10-acetyl-
3,7-dihydroxyphenoxazine; Invitrogen, Carlsbad, CA), which reacts with H2O2 in the 
presence of horseradish peroxidase to produce resorufin, a highly fluorescent molecule.  
HCAEC were cultured on 12-well plates and exposed to soluble UF (0, 50, and 100 µg/mL).  
Immediately following exposure, Amplex Red (150 μM) and HRP (0.8 U/ml) were added, 
and plates were analyzed at 5 min intervals for 30 min on a Bioassay HTS7000 plate reader 
(Perkin-Elmer, Wellesley, MA) with HTSoft version 1.0 software (PE Applied Biosystems, 
Weiterstadt, Germany).  Excitation wavelength was 535 nm and emission fluorescence was 
590 nm.  H2O2 was quantified by subtracting the baseline fluorescence from the final 
fluorescence, and normalizing these relative fluorescence units (RFU) to a standard curve of 
H2O2 (0-1 nm).  Following analysis, the endothelial cells were washed with PBS and cellular 
protein was collected with lysis buffer (20 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM 
EGTA, 1% Triton-X-100, pH 7.4) containing 1:100 Protease Inhibitor Cocktail Set 1 
(Calbiochem, La Jolla, CA).  Protein concentrations of cell lysates were measured using the 
Bio-Rad protein reagent (Bio-Rad, Richmond, CA) according to the manufacturer’s protocol.   
3.2.10  Intracellular H2O2 Detection using PG1 
Intracellular H2O2 was assessed using a small-molecule fluorophore probe Peroxy 
Green 1 (PG1; kindly provided by Dr. Christopher J. Chang, University of California-
Berkeley), which is highly specific for detection of H2O2 (Miller et al., 2007).  HCAEC were 
incubated with 5 µM PG1 for 15 min prior to exposure to soluble UF (0, 50, and 100 
µg/mL).  Immediately following exposure, PG1 fluorescence was measured in 1 min 
intervals for a total of 75 min using a PolarStar Optima microplate reader (BMG Labtech, 
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Durham, NC) with an excitation filter of 485/12 nm and emission fluorescence was read with 
a 525/30 nm filter.  Change in RFU was calculated for each dose by subtracting the baseline 
fluorescence from the final fluorescence.  Live cell imaging was conducted using a Nikon 
Eclipse C1Si confocal microscope (Nikon Instruments Inc., Melville, NY, USA) and 
instrument settings as previously described (Cheng et al., 2010).  Excitation was provided at 
488 nm and emission fluorescence was read with a 525/50 nm filter.  Imaging data was 
collected using Nikon EZ-C1 software and quantified by Nikon Elements (Nikon Instruments 
Inc., Melville, NY, USA) as previously described (Cheng et al., 2010).   
3.2.11 Western Blot Analysis 
30 µg of sample protein was mixed with 4X loading buffer (0.5 M Tris-HCL (pH 
6.8), 40% glycerol, 8% SDS, 10% β-mercaptoethanol and 0.04% bromophenol blue) and 
heated for 5 min at 95ºC.  Samples were added to the gel in equivalent amounts on adjacent 
lanes and separated by SDS-PAGE (PAGEr Gold Precast 4-20% Tris-Glycine gels, Lonza, 
Rockland, ME) with Precision Plus Protein Standards (Bio-Rad, Hercules, CA).  Proteins 
were transferred onto Trans-Blot Transfer Medium Pure Nitrocellulose (Bio-Rad, Hercules, 
CA) and incubated overnight with anti-NOX-4 primary rabbit antibody (Abcam Inc., 
Cambridge, MA) in 5% nonfat dry milk.  HRP-conjugated goat anti-rabbit IgG (Santa Cruz 
Biotechnology, Santa Cruz, CA) was used as a secondary antibody.   Protein bands were 
detected using ECL Western blotting detection reagents (Amersham Biosciences, 
Piscataway, NJ).  Blots were digitized using a Fujifilm LAS-3000 with Multigauge software 
(Fujifilm U.S.A., Valhall, NY).  The blots were stripped using Re-Blot Plus (Chemicon 
International, Temecula, CA) and re-probed with anti-α-tubulin primary mouse antibody 
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(Sigma, St. Louis, MO) with HRP-conjugated goat anti-mouse IgG (Santa Cruz 
Biotechnology, Santa Cruz, CA) used as the secondary antibody. 
3.2.12  siRNA Transfection 
HCAEC were transfected with 90 nM concentration of NOX-4 or scrambled #5 
siRNA (Ambion, Austin, TX) using siPORT Amine transfection agent (Ambion, Austin, TX) 
according to the manufacturer’s protocol.  Cells were used for experiments 48 hrs post-
transfection.   
3.2.13  Statistical Analysis 
Statistical analysis was performed using commercially available software (GraphPad 
Prism, version 4.03 for Windows; GraphPad Software, San Diego, CA).  A t-test or one-way 
ANOVA analysis followed by Bonferroni’s post-hoc test was used to compare exposed cells 
to control cells.  A p-value < 0.05 was considered statistically significant. 
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3.3 Results 
3.3.1  Soluble UF cause HCAEC to promote faster onset of TF-dependent thrombin 
generation and fibrin thrombus formation 
HCAEC were exposed to 10, 50, and 100 μg/mL soluble UF.  We found these doses 
are non-cytotoxic to the endothelial cells (Fig. 2.2F).  6 hrs following exposure, cells were 
assessed for functional coagulation balance using two methods.  We used the CAT assay to 
quantify thrombin generation (Fig. 3.1A-E) and the turbidity assay to measure the rate of 
fibrin thrombus formation (Fig. 3.1F-H) in PFP.  The CAT assay showed that lag time (Fig. 
3.1B) and time to peak (Fig. 3.1C) were significantly decreased with increasing doses of 
soluble UF, indicating faster onset of thrombin generation.  Exposure to soluble UF did not 
significantly affect the thrombin parameters ETP (Fig. 3.1D) and peak (Fig. 3.1E).  In the 
turbidity assay, HCAEC exposure to soluble UF led to a significant decrease in the onset 
time to thrombus formation (Fig. 3.1G) and an increase in Vmax (Fig. 3.1H), indicating faster 
onset and rate of fibrin thrombus formation.  These effects on thrombin and fibrin were 
abolished by addition of an inhibitory anti-human TF antibody.  These data show that soluble 
UF PM increases endothelial procoagulant activity and suggests this occurs via a TF-
dependent mechanism.   
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Figure 3.1 
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Figure 3.1  Exposure to soluble UF leads to faster onset of TF-dependent thrombin 
generation and fibrin thrombus formation.  The endothelial cell coagulation balance was 
assessed by measuring the ability of HCAEC to induce thrombin generation (A-E) and fibrin 
thrombus formation (F-H) in PFP following exposure to soluble UF (0, 10, 50, and 100 
µg/mL). Cells and PFP were incubated with either an inhibitory anti-human TF monoclonal 
antibody or a control mouse IgG. Thrombin parameters (B) lag time, (C) time to peak, (D) 
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ETP, and (E) peak and the fibrin thrombus parameters (G) thrombus formation onset and (H) 
Vmax were measured. Graphs are representative of 3 separate experiments with samples in 
triplicate.  * = p<0.05, ** = p<0.01, *** = p<0.001 compared to control. 
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3.3.2  Soluble UF increases TF mRNA expression in HCAEC 
To characterize the cause of soluble UF-induced changes in HCAEC cellular 
procoagulant activity, we measured mRNA expression of key cellular pro- and anticoagulant 
proteins by quantitative RT-PCR following exposure of the cells to soluble UF for 6 and 24 
hrs.  Exposure to 50 and 100 μg/mL of soluble UF led to a significant (p<0.001) 3.8-fold and 
5.1-fold, respectively, increase of TF mRNA expression in HCAEC at 6 hrs, and increased 
expression was sustained at 24 hrs (Fig. 3.2A).  Conversely, we found no significant changes 
in TFPI, EPCR, or thrombomodulin mRNA expression following exposure to soluble UF 
(Fig. 3.2B-D).  Additionally, immunofluorescence staining for thrombomodulin indicated the 
anticoagulant protein was not shed from the membrane of HCAEC exposed to of soluble UF 
(100 μg/mL).  The upregulation of TF and lack of compensatory changes in the anticoagulant 
proteins provide a mechanistic rationale for the increased cellular procoagulant activity seen 
in Figure 3.1.   
 
 
 
 
 
 
 
 
 
 
58 
 
Figure 3.2 
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Figure 3.2  Exposure to soluble UF leads to upregulation of TF.  (A-D) HCAEC were 
exposed to soluble UF (0, 10, 50, and 100 µg/mL) for 6 (white bars) or 24 hrs (black bars).  
Quantitative real time RT-PCR was used to determine mRNA expression of TF (A), TFPI 
(B), EPCR (C), and thrombomodulin (D).  For all mRNA, values were normalized to β-actin 
expression and are expressed as fold change in exposed cells over control.  n = 3 separate 
experiments with samples in triplicate.  (E) Representative images of HCAEC exposed to 0 
or 100 μg/mL soluble UF for 6 hrs followed by fixation with a 1:3 methanol:acetone mixture.  
HCAEC were stained for thrombomodulin (red fluorescence) and nuclei were labeled with 
DAPI (blue fluorescence).  n = 2 separate experiments.  *** = p<0.001 compared to control. 
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3.3.3  Soluble UF-induced TF upregulation is ROS dependent 
To characterize the initiating events leading to increased TF production, we first 
measured the mRNA expression of the proinflammatory cytokines IL-1β and TNF-α which 
are able to induce TF mRNA expression in endothelial cells (Dinarello, 1991).  Fast 
upregulation of these proinflammatory cytokines preceding an increase in TF would suggest 
that increases in TF mRNA expression are likely dependent on cytokine regulation following 
exposure to soluble UF.  We exposed HCAEC to 50 μg/mL soluble UF for 2, 4, 6, and 24 hrs 
and measured the mRNA expression of IL-1β, TNF-α, and TF.  There was an early and 
sustained significant increase in IL-1β (Fig. 3.3A) and TF (Fig. 3.3C) mRNA expression.  
Conversely, TNF-α mRNA levels (Fig. 3.3B) were not significantly induced following 
exposure to soluble UF. These data indicate that early induction of proinflammatory 
cytokines following exposure to soluble UF is not driving TF mRNA expression, suggesting 
parallel, and possibly independent mechanisms, upregulate proinflammatory and 
procoagulant proteins in this case. 
  TF gene expression and protein levels have been shown to be modulated by ROS in 
vascular cells (Herkert et al., 2004).  Since TF is a redox-regulated protein, we designed 
experiments to determine if ROS regulate TF gene expression changes following exposure to 
soluble UF.  We treated HCAEC with the PEG-SOD and PEG-catalase prior to 6 hr exposure 
to 50 μg/mL soluble UF and measured TF mRNA expression.  These cell-permeable 
antioxidants significantly (p<0.001) suppressed TF mRNA upregulation by soluble UF by 
55% and 36% respectively (Fig. 3.3D).  These data indicate that endothelial ROS production 
are required for increased TF mRNA expression in HCAEC following exposure to soluble 
UF.   
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Figure 3.3 
 
Figure 3.3  Soluble UF-induced upregulation of TF is ROS dependent.  (A-C) HCAEC 
were exposed to 0 or 50 μg/mL soluble UF for 2, 4, 6, or 24 hrs.  IL-1β (A), TNF-α (B), and 
TF (C) mRNA expression was quantified by real time RT-PCR.  (D) HCAEC were 
pretreated with PEG-SOD or PEG-Catalase (100 U/mL) for 1 hr and then exposed to 0 or 50 
μg/mL soluble UF for 6 hrs. TF mRNA expression was quantified by real time RT-PCR.  For 
all mRNA, values were normalized to β-actin expression and are expressed as fold change in 
exposed cells over control.  n = 3 separate experiments with samples in triplicate.  *** = 
p<0.001 compared to control. 
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3.3.4  Soluble UF exposure causes H2O2 production in HCAEC 
To characterize the cellular events leading to ROS production by endothelial cells, we 
then measured extracellular and intracellular H2O2 production in soluble UF-treated HCAEC.  
Using the Amplex Red assay to quantitate extracellular H2O2 release, we found an 11.8-fold 
(p<0.05) and 19.7-fold (p<0.001) increase in extracellular H2O2 production following 
HCAEC exposure to 50 and 100 μg/mL soluble UF, respectively (Fig. 2.2B).  Similar results 
were found for intracellular H2O2 production using the chemical indicator PG1.  In HCAEC 
exposed to 50 and 100 μg/mL of soluble UF, we observed a significant and progressive dose-
dependent increase in intracellular H2O2 in cells at 50 (21%, p<0.05) and 100 μg/mL (32%, 
p<0.001) (Fig. 3.4A).  We then visualized the distribution of H2O2 production in individual 
living cells in real time using confocal microscopy.  Soluble UF (100 μg/mL) induced 
intracellular H2O2 in HCAEC in a diffuse, cytoplasmic distribution as indicated by increases 
in PG1 fluorescence intensity (Fig. 3.4B).  Quantitative analysis of the confocal images 
indicate that compared to control cells, soluble UF induced a 2.9-fold increase (p<0.001) in 
RFU (Fig. 3.4C).  These data indicate that exposure to soluble UF results in immediate 
increases in extra- and intracellular H2O2 production in HCAEC.   
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Figure 3.4 
 
 
Figure 3.4  Exposure to soluble UF induces rapid H2O2 generation by HCAEC.  (A) 
HCAEC were incubated with the H2O2 chemical indicator PG1 and then exposed to soluble 
UF (0, 50, and 100 µg/mL) for 60 minutes. Fluorescence was measured with a fluorescent 
plate reader.  n = 3 independent experiments with samples in triplicate.  (B) Confocal 
microscopy was used to measure PG1 fluorescence in real time.  HCAEC were incubated 
with PG1 followed by a baseline read for 5 minutes. Cells were then exposed to 0 or 100 
μg/mL soluble UF for 30 minutes. Representative images in a pseudo-colored scheme are 
shown from baseline and 30 minutes post-exposure.  (C) Quantitative data from the confocal 
64 
 
images were gathered by outlining individual cells and measuring the RFU using Nikon NIS-
Elements software.  The data are represented as fold change over baseline measurement.  n = 
4 independent experiments.  * = p<0.05, ** = p<0.01, *** = p<0.001 compared to control. 
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3.3.5  ROS production from NOX-4 enzyme leads to upregulation of TF mRNA expression 
To determine the cellular source of soluble UF-induced H2O2 production, we 
measured extracellular H2O2 production by HCAEC in the presence of chemical inhibitors of 
the major sources of ROS production in endothelial cells.  We found that DPI, a NOX 
inhibitor, reduced extracellular H2O2 production in both the EA cells and the primary 
HCAEC exposed to soluble UF (Fig. 2.4D-E).  Similar to our findings in the EA cells, 
soluble UF-induced extracellular H2O2 levels were not affected by inhibitors of xanthine 
oxidases (allopurinol) or mitochondrial sources (KCN, rotenone), which are important 
additional sources of endothelial ROS production (data not shown), indicating that NOX 
enzymes are likely a major source of H2O2 production following exposure to soluble UF.  To 
determine if NOX enzymes mediate the increase in TF mRNA, we pretreated HCAEC with 
DPI followed by a 6 hr exposure to 50 μg/mL soluble UF.  Pretreatment with the NOX 
inhibitor led to a 50% attenuation (p<0.01) of the increased TF mRNA levels in exposed cells 
(Fig. 3.5A).   
HCAEC predominately express the NOX-4 isoform (Yoshida and Tsunawaki, 2008) 
and we confirmed that this NOX homolog was present in our endothelial cells (Fig. 3.5B).  
We more specifically probed the role of NOX-4 in soluble UF-induced TF mRNA 
production by transfecting HCAEC with NOX-4 siRNA.  Transfection resulted in 84% 
knockdown of the target gene mRNA levels as compared to the scrambled siRNA control 
after 48 hrs (Fig. 3.5C).  HCAEC were then transfected with NOX-4 or scrambled siRNA for 
48 hrs prior to exposure to soluble UF for 6 hrs.  Compared to cells transfected with 
scrambled siRNA, NOX-4 knockdown significantly (p<0.001) attenuated soluble UF- 
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induced TF mRNA upregulation by 56% (Fig. 3.5D).  Together, these data indicate that 
following exposure to soluble UF, ROS from the NOX-4 enzyme upregulates TF mRNA 
expression and endothelial cell-dependent procoagulant activity. 
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Figure 3.5 
 
Figure 3.5  TF mRNA expression following exposure to soluble UF requires ROS 
production and NOX-4.  (A) HCAEC were pretreated with DPI (50 µM) for 30 minutes and 
then exposed to 0 or 50 μg/mL soluble UF for 6 hrs. TF mRNA expression was quantified by 
real time RT-PCR.  (B) HCAEC cellular protein was analyzed for presence of the NOX-4 
isoform via Western blotting.  Total cellular protein was assessed by probing for α-tubulin.  
Samples are representative of 3 separate experiments.  (C) HCAEC were transfected with 
NOX-4 or scramble siRNA for 48 hrs. Quantitative RT-PCR was used to determine mRNA 
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expression of the target gene NOX-4 and non-target gene GAPDH.  (D) HCAEC were 
transfected with NOX-4 or scramble siRNA for 48 hrs and then exposed to 0 or 50 μg/mL 
soluble UF for 6 hrs. TF mRNA expression was quantified by real time RT-PCR.  For all 
mRNA, values were normalized to β-actin expression and are expressed as fold change over 
control.  n = 3 separate experiments with samples in duplicate.  * = p<0.05, ** = p<0.01 *** = 
p<0.001  
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3.4  Discussion 
There is a strong epidemiological evidence supporting a casual relationship between 
air particle pollution exposure and adverse CV health effects in humans that include clinical 
events mediated by thrombosis, such as acute coronary syndrome (Peters et al., 2001; Pope et 
al., 2006), stroke (Kettunen et al., 2007; Wellenius et al., 2012), deep venous thrombosis and 
thromboembolism (Baccarelli et al., 2008; Martinelli et al., 2012).  An important but 
understudied area in this field is the effect of inhaled air pollutants on vascular cells via 
soluble components that can translocate into the vasculature.  Here we report that the soluble 
components of UF PM induce a procoagulant phenotype in endothelial cells, supporting 
faster onset of thrombin generation and fibrin thrombus formation, and that these activities 
are driven by upregulation of TF.  We further show that this increase in TF mRNA is 
regulated by increased ROS production from NOX-4, and can be attenuated by treatment of 
cells with antioxidants or by inhibiting NOX-4.  These novel findings provide mechanistic 
insight into the enhanced thrombosis and endothelial dysfunction that underly increased risk 
for CV morbidity and mortality associated with air pollution exposure.   
Our results add to a growing body of evidence that link air pollution exposure to 
thrombosis.  Recent studies have demonstrated hypercoagulable effects of air pollution on 
plasma thrombin generation in human and animal models (Emmerechts et al., 2012; Kilinc et 
al., 2011; Rudez et al., 2009).  Emmerechts et al. demonstrated that elevated levels of coarse 
PM shortened the lag time of thrombin generation in microparticle-rich plasma obtained from 
diabetic individuals exposed to ambient air pollution (Emmerechts et al., 2012).  Our results 
extend these observations to potentially pathologic effects of PM on cellular procoagulant 
activity.  Specifically, we showed that exposure to soluble UF resulted in a dose-dependent 
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decrease in the lag time, which has been previously shown to be a sensitive reflection of TF 
activity (Ollivier et al., 2010).  We did not find a significant difference in ETP or peak 
thrombin following HCAEC exposure to soluble UF; however, this is not surprising since 
these parameters are typically more associated with alterations in the levels of soluble 
clotting factors (Machlus et al., 2009).  In vivo, we anticipate that these observed changes in 
plasma (Emmerechts et al., 2012; Kilinc et al., 2011; Rudez et al., 2009) and cellular 
procoagulant activity may be additive or even synergistic, ultimately dysregulating multiple 
thrombin generation parameters simultaneously.     
TF expression is generally suppressed in endothelial cells under normal physiological 
conditions but is induced by inflammation (Levi and van der Poll, 2005), endotoxin (Colucci 
et al., 1983), and exposure to air pollution (Karoly et al., 2007; Sun et al., 2008) in vitro and 
possibly in vivo (Mackman et al., 2007).  Activation of TF from injury or pathological 
conditions is typically balanced by expression of anticoagulant proteins such as TFPI 
(Crawley and Lane, 2008); however, our findings show lack of parallel upregulation of these 
anticoagulant proteins resulting in a procoagulant environment that favors thrombin 
generation.  The TF gene in primary endothelial cells contains binding sites for redox-
sensitive transcription factors (Herkert and Gorlach, 2002; Moll et al., 1995).  Accordingly, 
we found that in HCAEC, TF mRNA levels following exposure to soluble UF required both 
H2O2 and superoxide.  This finding supports previous studies showing that TF mRNA 
expression is attenuated in the presence of antioxidants following exposure to ionizing 
radiation and inflammatory cytokines (Szotowski et al., 2007).   
ROS are implicated in the pathogenesis and progression of CV diseases including 
atherosclerosis, hypertension, and diabetes (Madamanchi et al., 2005).  Additionally, 
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concentrations of 7-hydro-8-oxo-2’-deoxyguanosine in lymphocyte DNA was shown to be 
correlated with elevated levels of water-soluble transition metals in fine PM in humans 
exposed to ambient air pollution (Sorensen et al., 2005).  This measurement has been used as 
a biomarker to assess oxidative damage caused by increased ROS production and suggests 
oxidative stress following air pollution exposure.  We showed that soluble UF components 
lead to a significant increase in both extra- and intracellular endothelial H2O2 production 
immediately following exposure.  Our data strongly suggest that the ROS is made 
intracellularly as exposure to soluble UF caused an increase in PG1 fluorescence intensity, a 
chemical indicator specific for H2O2 with the ability to cross the cellular membrane (Miller et 
al., 2007).  This premise is further supported by confocal microscopy, which showed a 
cytoplasmic distribution of H2O2.   
NOX is an important source of ROS in vascular cells, and NOX enzymes have been 
implicated as a source of oxidative stress in numerous CV diseases (Griendling et al., 2000).   
While there are several major sources of ROS production in endothelial cells, exposure of 
mouse pulmonary microvascular endothelial cells to whole UF particles induced ROS 
production by NOX enzymes (Mo et al., 2009).  Our findings are important because we show 
that NOX-4 is a likely source of soluble UF-induced H2O2 production in endothelial cells 
from humans.  The intracellular distribution of NOX-4 is broad and has been shown to be 
variably located in the perinuclear space, endoplasmic reticulum, mitochondria, and nucleus 
of endothelial cells (Lassegue and Griendling, 2010; Lassegue et al., 2012).  Our data further 
suggest that NOX-4-derived ROS produced following exposure to soluble UF is cytoplasmic, 
but can escape to the extracellular space.  This finding has important implications for 
paracrine signaling effects by cellular H2O2. 
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Soluble UF-induction of NOX-4 increased TF mRNA expression in HCAEC.  Others 
have shown that after agonist stimulation by thrombin or platelet-derived products from 
activated human platelets, ROS from NOX enzymes induce TF mRNA expression in 
vascular smooth muscle cells (Gorlach et al., 2000; Herkert et al., 2002).  Our data extend 
this finding to endothelial cells after a more subtle stimulation with soluble UF.  NOX 
enzymes are important therapeutic targets for strategies trying to limit overproduction of 
ROS (Schramm et al., 2012) and our data reinforce the concept that inhibiting these enzymes 
is a potential approach to combat adverse CV effects from air pollution exposure.   
Our study has several strengths and limitations.  First, it is not known whether even 
the smallest PM can translocate from the lung into the vasculature and cause pathologic 
effects (Brown et al., 2002; Mills et al., 2006; Nemmar et al., 2002).  Indeed, we previously 
determined that the insoluble fraction of UF PM does not induce significant adverse 
responses in HCAEC (Figure 2.1D).  However, components of the water soluble fraction of 
particles, which include transition metals, appear in the vasculature following intratracheal 
instillation in rats (Wallenborn et al., 2009).  Our study strongly supports the potential for a 
pathogenic role for the water-soluble fraction of UF particles and implies that in cell culture 
systems, exposure to soluble UF is more physiologically relevant than whole UF particle 
exposures.  We used primary human coronary artery endothelial cells as our cellular model 
because these endothelial cells are among the first vascular cells to receive blood from the 
lungs and therefore, are likely to receive the highest concentration of any soluble components 
that transfer from the alveoli into the vasculature.  Despite these strengths, this study has 
potential limitations.  PM can cause cell death; however, we confirmed the doses used in this 
study were not cytotoxic (Figure 2.2B), indicating that the procoagulant activity following 
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exposure to soluble UF was due to endothelial activation rather than cellular death.  
Consequently, our findings suggest the observed effects are likely to be associated with 
chronic activation of coagulation and inflammation, with substantial potential for long-term 
pathologic effects.  Furthermore, the specific doses of PM experienced by HCAEC are not 
known.  However, individuals exposed to smoke or cooking fumes indoors can be exposed to 
elevated concentrations of UF particles similar to the doses used in this study(Karoly et al., 
2007).  These concentrations apply to amounts that would be experienced by alveolar 
epithelial cells and, by extension, the levels of the water-soluble fraction of UF PM 
experienced by cells in the vasculature.   
In summary, we have shown that exposure of HCAEC to soluble UF leads to 
increased production of intracellular ROS from the NOX-4 enzyme that regulates TF mRNA.  
This activation of the extrinsic pathway results in faster thrombin generation and fibrin 
thrombus formation.  These novel findings support and extend important information 
regarding mechanism(s) by which PM exposure results in thrombosis and adverse CV health 
effects.    
  
 
 
 
CHAPTER 4   
 
SOLUBLE COMPONENTS OF ULTRAFINE PARTICLES INDUCE 
PROINFLAMMATORY RESPONSES IN ENDOTHELIAL CELLS 
4.1 Introduction 
Cardiovascular (CV) disease is the leading cause of death and disability worldwide 
(Lauer, 2012), and a growing body of evidence suggests a strong association between 
exposure to air pollution and CV morbidity and mortality (Brook et al., 2004; Pope, 2009; 
Simkhovich et al., 2008).  Particulate matter (PM) is a major component of air pollution and 
has been shown to contribute to these adverse CV health effects in both epidemiological and 
toxicological studies.  For instance, individuals living in the greater Boston area had an 
increased risk of myocardial infarctions when PM concentrations were elevated (Peters et al., 
2001).  In addition, it was found that exposure to PM accelerated atherosclerotic progression 
in susceptible mouse (Sun et al., 2005) and rabbit models (Suwa et al., 2002).  Although 
these epidemiological and toxicological studies show a strong relationship between PM 
exposure and adverse CV health effects, the mechanisms behind these associations are 
currently not known.  
 PM is a heterogeneous mixture of extremely small particles and liquid droplets that 
are derived from a variety of manmade and natural sources (Poschl, 2005).  PM is 
categorized based on the diameter of the particle and increasing evidence suggests that 
ultrafine (UF) particles, which are the smallest diameter particle, are of particular importance 
in these adverse CV effects due to air pollution exposure (Donaldson and Stone, 2003).  For 
example, recent studies have shown that exposure to UF particles was associated with 
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hospitalizations for heart failure in Spain (Dominguez-Rodriguez et al., 2011) and 
cardiopulmonary and total mortality in Germany (Stolzel et al., 2007).  Soluble components 
of UF particles (soluble UF) can traverse the thin alveolar-capillary membrane to enter the 
circulation (Wallenborn et al., 2007) and interact with cells of the vasculature including 
endothelial cells.  These soluble components can lead to the formation of reactive oxygen 
species (ROS; Chapter 2), increase endothelial procoagulant activity (Chapter 3), and 
potentially cause proinflammatory responses. 
 Inflammation has been linked to numerous CV disorders including atherosclerosis 
(Libby, 2002), diabetes (Navarro and Mora, 2006), and chronic heart failure (Yndestad et al., 
2006).  Several studies have illustrated that exposure to PM leads to upregulation of various 
mediators of inflammation, such as proinflammatory cytokines and cell adhesion molecules, 
in lung bronchial epithelial cells (Fujii et al., 2001), alveolar macrophages (Sawyer et al., 
2009), and endothelial cells (Aung et al., 2011; Yatera et al., 2008).  Many of these 
inflammatory mediators are regulated by ROS and can be induced following activation of 
redox-sensitive transcription factors (Lavrovsky et al., 2000).  For example, PM exposure 
induces ROS production from NADPH oxidase (NOX) enzymes, an important source of 
endothelial ROS production, leading to the upregulation of the proinflammatory cytokines 
(Mo et al., 2009).  Furthermore, there is a strong cross-talk between the coagulation and 
inflammatory pathways (Levi and van der Poll, 2005) as tissue factor (TF) and thrombin are 
able to increase expression of proinflammatory cytokines (Cunningham et al., 1999; Levi et 
al., 2004b). 
 In addition to upregulating proinflammatory mediators, PM exposure increases the 
expression of oxidant sensitive molecules such as heme oxygenase 1 (HO-1) in alveolar 
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macrophages and bronchial epithelial cells (Li et al., 2003).  HO-1 catalyzes the degradation 
of heme to carbon monoxide, biliverdin, and iron.  Biliverdin is further reduced to bilirubin, 
both of which are known to have antioxidant properties (Wu et al., 2011).  Furthermore, HO-
1 is an inducible protein in response to oxidative stress and has been shown to be regulated 
by ROS generated from NOX enzymes in murine macrophages exposed to a lipid metabolite 
derived from prostaglandin D2 (Hong et al., 2008).   
In Chapter 3, we show that endothelial cells exposed to soluble UF induce 
procoagulant responses that are dependent upon increased ROS production and the NOX-4 
enzyme.  The objective of this study was to determine if soluble components of UF particles 
induce proinflammatory responses and HO-1 upregulation in human endothelial cells, and to 
define the mechanisms behind these effects.  We show here that endothelial cells exposed to 
soluble UF increase mRNA expression of proinflammatory cytokines, cell adhesion 
molecules, and HO-1 that is dependent upon increased ROS production and NOX enzymes.  
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4.2 Materials and Methods  
4.2.1  Reagents and Chemicals 
 The immortalized endothelial cell line, EA.hy926 (EA cells), are derived by fusing 
human umbilical vein endothelial cells with A549 cells, a human lung adenocarcinoma 
epithelial cell line (Edgell et al., 1983).   EA cells were obtained from University of North 
Carolina’s Tissue Culture Facility (Chapel Hill, NC).  Dulbecco’s modified Eagle’s medium 
(DMEM)-high glucose, fetal bovine serum (FBS), and antibiotic-antimycotic (100X) were 
obtained from Gibco (Grand Island, NY). Human coronary artery endothelial cells 
(HCAEC), endothelial growth medium (EGM-2), and EGM-2 Bullet Kit were obtained from 
Lonza (Walkersville, MD).  All other chemicals and reagents were from Sigma Chemical 
Company (St. Louis, MO) unless otherwise stated. 
4.2.2  Cell Culture 
EA cells were cultured in DMEM-high glucose medium supplemented with 10% FBS 
and 1% antibiotic-antimycotic mix.  HCAEC were cultured in EGM-2 media supplemented 
with the EGM-2 Bullet Kit (2% FBS, 0.4% rhFGF-B, 0.1% gentamicin sulfate amphotericin-
B, 0.1% rhEGF, 0.1% heparin, 0.1% ascorbic acid, 0.1% R
3
-IGF-1, 0.1% VEGF, and 0.04% 
hydrocortisone).  HCAEC were obtained from two donors with no known history of CV 
disease.  Cells were grown to confluence and used between passages 5-8.   
4.2.3  Ultrafine Particles 
UF particles were collected from February to May 2007 in Chapel Hill, NC as 
previously described (Becker et al., 2005).  UF particles were analyzed for chemical 
components by the Research Triangle Institute (Research Triangle Park, NC) and the 
composition of these particles is expressed relative to UF particle mass (ng/mg; Table 2.1).  
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The soluble fraction of these particles was acquired by suspending the particles in PBS at the 
desired concentration and centrifuging the resultant suspension for 30 minutes at 20,000 x g.  
The supernatant from the pelleted particles was collected and used as the soluble fraction.   
4.2.4  Real-Time Quantitative PCR 
Relative gene expression in EA and HCAEC were obtained using quantitative RT-
PCR.  Total RNA was isolated from the endothelial cells using an RNeasy kit (Qiagen, 
Valencia, CA) according to the manufacturer’s protocol.  RNA was quantified using a 
Nanodrop™ 1000 Spectrophotometer (Thermo Scientific, Wilmington, DE).  cDNA was 
generated as previously described (Karoly et al., 2007).  Oligonucleotide primer pairs and 
fluorescent probes for β-actin (forward, 5’-CCTGGCACCCAGCACAAT-3’; reverse, 5’-
GCCGATCCACACGGAGTACT-3’; probe, 5’-
ATCAAGATCATTGCTCCTCCTGAGCGC-3’)  and TF (forward, 5’-
TTGGCACGGGTCTTCTCCTA-3’; reverse, 5’-CGAGGTTTGTCTCCAGGTAAGG-3’; 
and probe,  5’-AGAACCGGTGCTCTCCACATTCCCTG-3’) were designed using Primer 
Express (Applied Biosystems) and obtained from Integrated DNA Technologies (Coralville, 
IA).  IL-8, IL-1β, IL-6, TNF-α, MCP-1, GM-CSF, E-selectin, ICAM-1, HO-1, NOX-4, and 
GAPDH primer pairs and fluorescent probe sets were obtained as Taqman pre-developed 
assay reagents from Applied Biosystems (Foster City, CA).  Quantitative fluorogenic 
amplification of cDNA was performed using the ABI Prism 7500 Sequence Detection 
System (Applied Biosystems, Foster City, CA), primer and probe sets of interest, and 
Taqman Universal PCR Master Mix (Applied Biosystems, Foster City, CA).  Standard 
curves generated from a serially diluted standard pool of cDNA prepared from cultured 
human endothelial cells exposed to 100 ng/mL TNF-α for 6 hrs were used to determine the 
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relative abundance of mRNA levels.  The relative abundance of β-actin mRNA was used to 
normalize levels in genes of interest. 
4.2.5  siRNA Transfection 
HCAEC were transfected with 90 nM concentration of NOX-4 or scrambled #5 
siRNA (Ambion, Austin, TX) using siPORT Amine transfection agent (Ambion, Austin, TX) 
according to the manufacturer’s protocol.  Cells were used for experimentations 48 hrs post-
transfection.  
4.2.6  Statistical Analysis  
Statistical analysis was performed using commercially available software (GraphPad 
Prism, version 4.03 for Windows; GraphPad Software, San Diego, CA).  A one-way 
ANOVA analysis followed by Bonferroni’s post-hoc test was used to compare exposed cells 
to control cells.  A p-value < 0.05 was considered statistically significant. 
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4.3 Results 
4.3.1  Soluble UF induces IL-8 mRNA expression in EA cells 
 To determine if exposure to soluble UF induces proinflammatory responses in 
endothelial cells, we first exposed EA cells to soluble UF (10, 50, and 100 μg/mL) for 6 and 
24 hrs and measured the mRNA expression of the proinflammatory cytokine IL-8.  Exposure 
to 50 and 100 μg/mL soluble UF led to a significant (p<0.001) 2.1-fold and 1.9-fold increase, 
respectively, of IL-8 mRNA expression in EA cells at 24 hrs post-exposure (Fig. 4.1).  These 
data indicate that exposure to soluble UF leads to proinflammatory responses in EA cells.   
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Figure 4.1 
 
Figure 4.1  Exposure to soluble UF leads to upregulation of IL-8 in EA cells.  EA cells 
were exposed to soluble UF (0, 10, 50, and 100 µg/mL) for 6 (white bars) or 24 hrs (black 
bars).  Quantitative real time RT-PCR was used to determine mRNA expression of IL-8.  
Values were normalized to β-actin expression and are expressed as fold change in exposed 
cells over control.  n = 3 separate experiments with samples in triplicate.  * = p<0.05, ** = 
p<0.01, *** = p<0.001 compared to control. 
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4.3.2  Soluble UF induces mRNA expression of proinflammatory cytokines in HCAEC 
After illustrating that exposure to soluble UF induces proinflammatory responses in 
an immortalized endothelial cell line, we exposed HCAEC to soluble UF for 6 and 24 hrs and 
measured the mRNA expression of several proinflammatory cytokines in order to assess the 
response in a primary cell model.  Exposure to soluble UF (10, 50, and 100 μg/mL) in 
HCAEC increased the mRNA expression of the proinflammatory cytokines IL-8 (Fig. 4.2A), 
IL-1β (Fig. 4.2B), MCP-1 (Fig. 4.2C), and GM-CSF (Fig. 4.2D).  Although there was not a 
significant change in IL-6 (Fig. 4.2E) or TNF-α (Fig. 4.2F), there was a trend towards an 
increase in the mRNA expression of these proinflammatory cytokines following exposure to 
soluble UF.  These data indicate that soluble UF exposure induces proinflammatory 
responses in primary endothelial cells.  
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Figure 4.2 
 
Figure 4.2  Exposure to soluble UF leads to upregulation of proinflammatory cytokines 
in HCAEC.  (A-F) HCAEC were exposed to soluble UF (0, 10, 50, and 100 µg/mL) for 6 
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(white bars) or 24 hrs (black bars).  Quantitative real time RT-PCR was used to determine 
mRNA expression of the proinflammatory cytokines IL-8 (A), IL-1β (B), MCP-1 (C), GM-
CSF (D), IL-6 (E), and TNF-α (F).  For all mRNA, values were normalized to β-actin 
expression and are expressed as fold change in exposed cells over control.  n = 3 separate 
experiments with samples in triplicate.  * = p<0.05, ** = p<0.01, *** = p<0.001 compared to 
control. 
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4.3.3  Soluble UF induces mRNA expression of cell adhesion molecules in HCAEC 
Altered expression of endothelial cell adhesion molecules have been implicated in the 
pathogenesis of several CV diseases (Blankenberg et al., 2003).  To determine if exposure to 
soluble UF induces the expression of cell adhesion molecules in endothelial cells, we 
exposed HCAEC to soluble UF (10, 50, and 100 μg/mL) for 6 and 24 hrs and observed a 
significant increase in the mRNA expression of the cell adhesion molecules E-selectin (Fig. 
4.3A) and ICAM-1 (Fig. 4.3B).  Enhanced mRNA expression of these key cell adhesion 
molecules and proinflammatory cytokines from Figure 4.2 indicate that exposure to soluble 
UF results in endothelial activation in primary endothelial cells (Figure 1.2). 
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Figure 4.3 
 
Figure 4.3  Exposure to soluble UF leads to upregulation of cell adhesion molecules in 
HCAEC.  (A-B) HCAEC were exposed to soluble UF (0, 10, 50, and 100 µg/mL) for 6 
(white bars) or 24 hrs (black bars).  Quantitative real time RT-PCR was used to determine 
mRNA expression of the cell adhesion molecules E-selectin (A) and ICAM-1 (B).  For all 
mRNA, values were normalized to β-actin expression and are expressed as fold change in 
exposed cells over control.  n = 3 separate experiments with samples in triplicate.  * = p<0.05, 
** = p<0.01, *** = p<0.001 compared to control. 
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4.3.4  Soluble UF increases HO-1 expression in HCAEC   
 UF exposure has been shown to increase the expression of the oxidant stress-
inducible protein HO-1 in macrophages and epithelial cells (Li et al., 2003).  To determine if 
exposure to soluble UF induces HO-1 mRNA levels in primary endothelial cells, we exposed 
HCAEC to 10, 50, and 100 μg/mL soluble UF for 6 and 24 hrs and measured the mRNA 
expression.  Exposure to 50 and 100 μg/mL soluble UF caused a significant (p<0.001) 
increase in the mRNA expression of HO-1in HCAEC at both time points (Fig. 4.4).  These 
data indicate that exposure to soluble UF increases oxidative stress in endothelial cells 
resulting in endothelial activation. 
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Figure 4.4 
 
Figure 4.4  Exposure to soluble UF leads to upregulation of HO-1 in HCAEC.  HCAEC 
were exposed to soluble UF (0, 10, 50, and 100 µg/mL) for 6 (white bars) or 24 hrs (black 
bars).  Quantitative real time RT-PCR was used to determine mRNA expression of the 
oxidative stress responsive protein HO-1.  Values were normalized to β-actin expression and 
are expressed as fold change in exposed cells over control.  n = 3 separate experiments with 
samples in triplicate.  *** = p<0.001 compared to control. 
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4.3.5  ROS production from NOX enzymes lead to upregulation of IL-1β and HO-1 mRNA 
expression  
ROS are key intermediates in inducing gene expression of certain proinflammatory 
cytokines, adhesion molecules, and stress response genes like HO-1 (Lee and Yang, 2012).  
In Chapter 3, we showed that HCAEC exposed to soluble UF induce procoagulant responses 
that are dependent upon increased ROS production and NOX-4.  To determine if ROS from 
NOX enzymes mediate the increases in mRNA expression of the key proinflammatory 
cytokines, cell adhesion molecules, and HO-1 by soluble UF (Fig. 4.2, 4.3, and 4.4), we 
pretreated HCAEC with DPI followed by a 6 hr exposure to 50 μg/mL soluble UF.  
Pretreatment with the NOX inhibitor attenuated the increase in IL-1β (Fig. 4.5A) and HO-1 
(Fig. 4.5B) mRNA levels by 62% and 57%, respectively, in HCAEC exposed to soluble UF.  
Conversely, we found no significant changes in the soluble UF-induced mRNA expression of 
the other proinflammatory markers from Figure 4.2 in HCAEC pretreated with DPI (data not 
shown). 
Since HCAEC predominately express the NOX-4 isoform (Yoshida and Tsunawaki, 
2008) and we have confirmed that this NOX homolog is present in our endothelial cells (Fig. 
3.5B), we specifically probed the mechanistic role of NOX-4 in soluble UF-induced IL-1β 
and HO-1 mRNA production by transfecting HCAEC with NOX-4 siRNA.  Initial 
assessment of the NOX-4 siRNA efficiency resulted in an 84% knockdown of the target gene 
mRNA levels as compared to the scrambled siRNA control 48 hrs after transfection (Fig. 
3.5C).  Following verification of knockdown, HCAEC were then transfected with NOX-4 or 
scrambled siRNA for 48 hrs prior to exposure to soluble UF for 6 hrs.  Compared to cells 
transfected with scrambled siRNA, NOX-4 knockdown significantly (p<0.05) attenuated 
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soluble UF-induced HO-1 mRNA upregulation by 30% (Fig. 4.5D); however, we found no 
significant changes in soluble UF-induced IL-1β mRNA expression in NOX-4 transfected 
HCAEC (Fig. 4.5C).  Together, these data indicate that following exposure to soluble UF, 
ROS from NOX enzymes upregulate HO-1 and IL-1β mRNA expression, while ROS from 
NOX-4 specifically contributes to increases in HO-1 mRNA expression.   
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Figure 4.5 
 
Figure 4.5  IL-1β and HO-1 mRNA expression following exposure to soluble UF 
requires ROS production from NOX enzymes.  (A-B) HCAEC were pretreated with DPI 
(50 µM) for 30 minutes and then exposed to 0 or 50 μg/mL soluble UF for 6 hrs.  IL-1β (A) 
and HO-1 (B) mRNA expression was quantified by real time RT-PCR.  (C-D) HCAEC were 
transfected with NOX-4 or scramble siRNA for 48 hrs and then exposed to 0 or 50 μg/mL 
soluble UF for 6 hrs.  IL-1β (C) and HO-1 (D) mRNA expression was quantified by real time 
RT-PCR.  For all mRNA, values were normalized to β-actin expression and are expressed as 
fold change over control.  n = 3 separate experiments with samples in duplicate.  * = p<0.05, 
** = p<0.01 *** = p<0.001 compared to control. 
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4.4 Discussion 
 Increasing evidence shows a strong association between exposure to air pollution and 
CV morbidity and mortality (Baccarelli et al., 2008; Mann et al., 2002; Pope et al., 2004) but 
the mechanisms behind this relationship remain unknown.  An important area of research that 
needs to be further investigated is determining if components of PM lead to endothelial 
activation, which could link inhaled air pollutants to vascular dysfunction.  Here we report 
that exposure to the soluble components of UF particles increase the expression of 
proinflammatory cytokines and cell adhesion molecules in endothelial cells.  We further 
show that soluble UF exposure induces the expression of the oxidant stress-inducible protein 
HO-1.  These responses, which indicate endothelial activation, were dependent upon 
increased ROS production and NOX enzymes.  These novel findings provide mechanistic 
insight into the proinflammatory responses and endothelial dysfunction that may contribute 
to the pathophysiology of CV diseases associated with exposure to air pollution. 
 Our results add to a growing body of literature indicating that air pollution exposure 
leads to proinflammatory responses in humans (Ghio and Devlin, 2001), animal models 
(Ferraro et al., 2011), and in vitro models (Aung et al., 2011; Fujii et al., 2001; van Eeden et 
al., 2001).  A majority of these in vitro studies examining the adverse cellular responses to 
PM have generally been investigated in cultured lung epithelial cells and macrophages; 
however, a recent study by Aung et al. demonstrated that exposure to fine and UF particles 
induce E-selectin, IL-6, TNF-α, and MCP-1 in human aortic endothelial cells (Aung et al., 
2011).  Our findings extend this observation by illustrating that exposure to the soluble 
components of UF particles, which are more biologically relevant as they have a higher 
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chance of entering the vasculature, increase the gene expression of proinflammatory 
cytokines and cell adhesion molecules in endothelial cells.   
 The elevated expression of these proinflammatory mediators and increased 
endothelial procoagulant activity we demonstrated in Chapter 3 indicate that exposure to 
soluble UF leads to endothelial activation in cultured primary endothelial cells (Hunt and 
Jurd, 1998).  Endothelial cell activation increases vascular coagulation and inflammation in 
vivo, and is involved in the pathogenesis of several CV diseases including atherosclerosis and 
hypertension (Lwaleed et al., 2007; Sprague and Khalil, 2009).  In addition, endothelial 
dysfunction contributes to the formation of venous and arterial thrombosis, which upon 
rupture may lead to myocardial infarctions or strokes (Lowe, 2008).  Recent studies have 
demonstrated that exposure to elevated levels of PM can increase the risk of deep vein 
thrombosis, myocardial infarctions, and strokes (Baccarelli et al., 2008; Kettunen et al., 2007; 
Murakami and Ono, 2006), supporting the concept that endothelial activation may contribute 
to vascular dysfunction following air particle pollution exposure (Figure 1.2). 
 HO-1 is an oxidant sensitive molecule that is the rate-limiting enzyme in the 
degradation of heme, resulting in the production of metabolites that have antioxidant 
properties (Li and Shah, 2004).  PM exposure has been shown to increase HO-1 expression 
in alveolar macrophages and bronchial epithelial cells (Li et al., 2003) and our data extend 
these findings by illustrating that exposure to soluble UF induces the expression of HO-1 in 
endothelial cells.  Pharmacological induction or overexpression of HO-1 has been shown to 
exert protective antioxidant, anti-inflammatory, and anticoagulant properties (Fan et al., 
2012; Kawamura et al., 2005; Panahian et al., 1999).  For example, induction of HO-1 in 
human aortic endothelial cells attenuated the induced proinflammatory effects and 
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endothelial dysfunction caused by exposure to oxidized low-density lipoprotein and TNF-α 
(Kawamura et al., 2005).  HO-1 has emerged as therapeutic target for the treatment of CV 
disorders (Durante, 2010).  Our studies demonstrate that exposure to soluble UF induces 
oxidant production (Chapter 2), increases endothelial procoagulant activity (Chapter 3), and 
elevates the expression of proinflammatory mediators (Chapter 4) in the presence of 
increased HO-1 expression; however, targeting this antioxidant protein may still be a viable 
therapeutic option when trying to combat adverse CV effects associated with air pollution 
exposure.     
Pathological increases in ROS production can lead to oxidative stress and cellular 
damage resulting in the pathogenesis and progression of a variety of CV diseases 
(Madamanchi et al., 2005).  NOX enzymes are an important source of vascular ROS 
production and NOX-derived oxidative stress has been implicated in the pathogenesis of 
several CV disorders including atherosclerosis and diabetes (Griendling et al., 2000).  We 
have previously shown that exposure to soluble UF induces ROS production from NOX 
enzymes leading to the upregulation of TF and increased endothelial procoagulant activity 
(Chapter 3).  Additional studies have demonstrated that air pollution induces ROS from NOX 
enzymes that contributes to proinflammatory responses in mouse pulmonary microvascular 
endothelial cells (Mo et al., 2009) and the upregulation of HO-1 in a human bronchial 
epithelial cell line (Cheng et al., 2012).  Our data further these findings by demonstrating that 
the soluble components of UF PM can induce proinflammatory responses and HO-1 
upregulation via ROS from NOX enzymes in human endothelial cells.  It has become 
apparent that NOX enzymes are critical therapeutic targets when trying to combat oxidative 
stress-induced vascular diseases (Schramm et al., 2012), and our data further this notion that 
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targeting NOX enzymes is a viable therapeutic option to address adverse CV effects caused 
by exposure to air pollution.   
In summary, we have shown that exposure to soluble UF increases the expression of 
proinflammatory mediators and HO-1 in endothelial cells resulting in endothelial activation.  
These changes were shown to be regulated by ROS from NOX enzymes.  These novel 
findings provide mechanistic insight into the proinflammatory responses and endothelial 
dysfunction that may contribute to the adverse CV health effects associated with PM 
exposure.  
  
 
 
CHAPTER 5  
 
OVERALL CONCLUSIONS AND SIGNIFICANCE 
 Increasing evidence suggests a strong association between exposure to air pollution 
and cardiovascular (CV) morbidity and mortality, but the mechanisms behind this 
relationship are currently not known.  Ultrafine (UF) particles deposit in the heavily 
vascularized region of the lung, and the soluble components of UF particles (soluble UF) are 
able to cross from the lung into the circulation and adversely affect cells of the vasculature 
such as endothelial cells.  Endothelial activation and initiation of coagulation are 
pathophysiological mechanisms that could link inhaled air pollutants to vascular dysfunction.  
These studies investigated the adverse endothelial responses following exposure to soluble 
UF.  In Chapter 2, we demonstrated that soluble UF induced H2O2 release from NADPH 
oxidase (NOX) enzymes in endothelial cells.  This increase in reactive oxygen species (ROS) 
production was dependent on transition metals present in the soluble fraction.  In Chapter 3, 
we illustrated an increase in intracellular H2O2 production from the NOX-4 enzyme that 
regulated the expression of the procoagulant protein tissue factor (TF) in endothelial cells 
exposed to soluble UF.  These procoagulant responses led to activation of the extrinsic 
coagulation pathway, which triggered faster onset of thrombin generation and fibrin 
thrombus formation.  In Chapter 4, we showed that exposure to soluble UF increased the 
expression of proinflammatory cytokines, cell adhesion molecules, and the oxidant stress-
inducible protein HO-1 in endothelial cells.  These adverse endothelial responses were 
regulated by ROS from NOX enzymes.  Collectively, these studies demonstrate that exposure 
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to the soluble components of UF particles induced ROS production from NOX enzymes that 
regulate procoagulant and proinflammatory responses in endothelial cells resulting in 
endothelial activation and a prothrombotic phenotype (Figure 1.6).  These novel findings 
provide mechanistic insight into the endothelial dysfunction that may contribute to the 
adverse CV health effects associated with PM exposure. 
 Endothelial cells are critical components of the vasculature as they are involved in 
hemostatic balance, blood cell trafficking, and permeability (Aird, 2007).  Endothelial 
activation typically involves increases in cell adhesion molecules, induction and release of 
proinflammatory mediators, a shift towards a prothrombotic phenotype, and altered 
permeability (Aird, 2006). Thus, endothelial activation following exposure to air pollution 
may play a fundamental role in the progression of CV diseases.  Over the course of these 
studies, we have demonstrated that exposure to soluble UF: 1) induces ROS production 
(Chapter 2), 2) increases endothelial procoagulant activity (Chapter 3), and 3) elevates 
expression of proinflammatory mediators (Chapter 4); all of which indicate endothelial 
activation following exposure to particulate air pollution.  These pro-oxidant, 
proinflammatory, and procoagulant responses contribute to a prothrombotic endothelial 
phenotype and may lead to inappropriate regulation of vascular tone, permeability, 
coagulation, fibrinolysis, cell adhesion, and proliferation following exposure to air pollution 
(Calderon-Garciduenas et al., 2008). 
To investigate the mechanisms that contribute to soluble UF-induced endothelial 
activation, we utilized an immortalized endothelial cell line (EA cells) and primary human 
coronary artery endothelial cells (HCAEC) as in vitro models.  As an immortalized cell line, 
EA cells maintained most of the characteristics of endothelial cells, were fast growing, and of 
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ample supply.  Therefore, these cells were ideal for exploring possible adverse endothelial 
responses following exposure to soluble UF.  However, EA cells were derived by fusing 
human umbilical vein endothelial cells with a human lung adenocarcinoma epithelial cell 
line, A549 cells (Edgell et al., 1983), and might not fully represent adverse responses induced 
in primary endothelial cells.  In fact, we show that although the trends were analogous, 
HCAEC had substantially augmented responses in extracellular ROS production (Chapter 2) 
and TF mRNA expression (data not shown) as compared to that in the EA cell line following 
exposure to soluble UF.   
For our primary endothelial cell model, we used HCAEC obtained from the coronary 
artery of two male, Caucasian donors with no known history of CV disease.  The coronary 
artery is one of the first blood vessels to receive fresh oxygenated blood from the lung.  The 
endothelial cells that line this blood vessel will accordingly be exposed to relatively high 
concentrations of any soluble components that traverse from the lung into the vasculature, 
making it an ideal model to investigate the adverse endothelial responses following exposure 
to soluble UF.  A bulk of the experiments in this project were carried out using primary 
endothelial cells from only Donor 2 due to lack of commercially available stocks of early 
passage HCAEC from Donor 1.  However, the experiments investigating the changes in 
mRNA expression of pro- and anticoagulant proteins (Chapter 3) and proinflammatory 
mediators (Chapter 4) were carried out using endothelial cells from both donors.  It is 
interesting to note that although both donors demonstrated the same trend in expression of 
these key coagulant and inflammatory proteins, the magnitude of response was different.  
This can be most clearly identified by examining IL-1β mRNA expression following soluble 
UF exposure (Fig. 4.2B).  The error bars on this graph are considerable due to the differences 
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in the magnitude of responses between the two donors.  For example, Donor 1 had a 12.1-
fold increase in IL-1β mRNA expression following exposure to 100 μg/ml soluble UF for 24 
hrs, whereas Donor 2 had a 3.8-fold following the same exposure.  Although both donors 
responded to soluble UF exposure by increasing the expression of this proinflammatory 
cytokine, Donor 1 was more responsive.  This divergence in response may be explained by 
the age difference of the two donors (Donor 1 age – 57; Donor 2 age – 21).  This data 
supports findings by Schneider et al. who observed significant differences in the rate of 
fibroblast migration, cellular senescence, cell population replication rate, and cell number at 
confluency from skin fibroblast cultures derived from healthy old and young volunteers 
(Schneider and Mitsui, 1976).  Unknown genetic aspects may also play a role in the 
variability of adverse responses following an air pollution exposure (Kleeberger, 2003).   
This finding brings up an interesting concept to explore in future studies.  It is known 
that individuals will respond differently to the same air pollution exposure.  Susceptible 
populations, such as individuals with preexisting CV or pulmonary disease, the elderly, or 
small children, are at an increased risk to severe air pollution episodes (Brook et al., 2004).  
Recent studies have begun comparing the adverse responses of primary airway epithelial 
cells obtained from asthmatic or non-asthmatic individuals to particulate matter (PM) 
exposure (Duncan et al., 2012).  These researchers have discovered that epithelial cells from 
the susceptible population exhibit differential responses following exposure to particulate air 
pollution.  Extrapolating further, these data suggest that endothelial cells obtained from 
individuals with a known history of CV disease, or other susceptible populations, might 
respond differently to air particle pollution exposure.  Comparing the responses of 
endothelial cells from normal and susceptible populations to a soluble UF exposure would be 
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an interesting follow up experiment to further elucidate the mechanisms that link air 
pollution exposure and CV disease.  
PM is a major component of air pollution as well as a primary contributor to CV 
morbidity and mortality associated with ambient air pollution exposure (Anderson et al., 
2012).  One of the first objectives in this project was to determine the relevant size, fraction, 
and dose of PM to use throughout the experiments (Chapter 2).  Increasing epidemiological 
evidence suggests that although elevated levels of coarse and fine PM induce adverse CV 
effects (Harrison and Yin, 2000; Polichetti et al., 2009), UF PM exposure is more 
significantly correlated with CV and pulmonary diseases (Belleudi et al., 2010; Franck et al., 
2011).  We demonstrated that the soluble fraction of UF PM induced extracellular ROS 
production in endothelial cells; whereas, both the soluble and insoluble fraction of coarse and 
fine PM contributed to increases in ROS production following exposure (Chapter 2).  This 
finding is important because it further supports the concept that the water soluble 
components of UF particles, which are capable of translocating to the vasculature, are 
responsible for the adverse CV effects associated with PM exposure.   
UF particles are more toxic and inflammogenic compared to larger sized particles of 
same material when delivered at the same mass dose (Stone et al., 2007).  This is most likely 
due to the significantly greater collective particle surface area that allows for adsorption of 
toxic substances such as organic compounds and transition metals (Sioutas et al., 2005).  In 
addition, the small diameter of UF particles make them more likely to deposit in the heavily 
vascularized alveolar region of the lung (Kreyling et al., 2004).  UF particles are able to 
evade critical lung defenses, such as recognition and phagocytosis by alveolar macrophages 
(Gonzalez et al., 1996) and mucociliary clearance (Kreyling et al., 2006), to remain longer in 
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the lung and thus increase the possibility of inducing adverse cardiopulmonary effects.  For 
these reasons, we chose to study the water soluble fraction of UF particles for this project.   
The EPA monitors coarse and fine PM due to the Clear Air Act but do not currently 
regulate air pollution particles in the UF size range.  These particles are extremely small 
making them difficult to capture on a filter, which contributes to the insufficient amounts of 
available information pertaining to their concentrations and physical/chemical properties 
(Sioutas et al., 2005). These data suggest that an emphasis must be placed on developing new 
technologies to measure ambient levels of UF PM in effort to facilitate a better understanding 
of their contribution to CV morbidity and mortality. 
 The emerging nanotechnology industry is incorporating nanoparticles, which are in 
the same size range as UF PM, into everyday products such as electronics, food, medicines, 
and cosmetics (Stone et al., 2007).  Although applications of engineered nanoparticles have 
the potential to enhance quality of life by advancing scientific knowledge and improving 
existing products, they also have the potential to become aerosolized and induce adverse 
cardiopulmonary effects.  Recent studies have demonstrated that an assortment of 
nanoparticles (i.e. carbon nanotubes, fullerenes, TiO2) are capable of inducing CV, 
pulmonary, and systemic adverse responses in in vivo models (Shannahan et al., 2012).  
Nanomaterials, like UF particles, are not currently regulated, and human exposure will only 
increase as this rapidly growing field expands into new products (Li et al., 2008).  Further 
research needs to be conducted to understand the potential adverse human health effects 
following exposure to these intentionally engineered UF-sized particles. 
Physiological levels of ROS are produced as intercellular signaling molecules to 
initiate signaling cascades involved in basic cellular functions such as cell growth, 
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metabolism, and cell death (D'Autreaux and Toledano, 2007).  However, under 
pathophysiological conditions, ROS can be produced at an elevated rate, resulting in 
oxidative stress and cellular damage that has been implicated in the pathogenesis and 
progression of several CV diseases (Madamanchi et al., 2005).  Moreover, PM exposure 
increases ROS production and oxidative stress in in vitro models (Mo et al., 2009; Montiel-
Davalos et al., 2012), animal models (Araujo et al., 2008; Lei et al., 2005), and human 
volunteers (Sorensen et al., 2005).  Our data expands on these studies by demonstrating that 
exposure to soluble UF induces elevated levels of extracellular (Chapter 2) and intracellular 
(Chapter 3) endothelial H2O2 production immediately following exposure.  These findings 
suggest that PM-induced ROS production is a critical component in the development of CV 
diseases.  
Most signaling events initiated by ROS are thought to occur through the H2O2 
molecule, which is capable of oxidizing cysteine residues on target proteins to initiate signal 
transduction cascades (Rhee et al., 2000), and activating transcription factors leading to the 
induction of redox-sensitive genes (Schmidt et al., 1995).  H2O2 is a membrane soluble 
molecule that is detectable both extra- and intracellularly.  Our data strongly suggest that 
soluble UF-induced H2O2 production is made intracellularly as endothelial cell exposure to 
this fraction led to an increase in the fluorescence intensity of PG1, a chemical indicator 
specific for H2O2 with the ability to cross the cellular membrane (Miller et al., 2007).  This 
premise is further supported by confocal microscopy, which showed a cytoplasmic 
distribution of H2O2 (Chapter 3).  Our findings indicate soluble UF-induced ROS production 
derives from the NOX-4 enzyme, which has a broad intracellular distribution and is shown to 
be variably located in the perinuclear space, endoplasmic reticulum, mitochondria, and 
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nucleus of endothelial cells (Lassegue and Griendling, 2010; Lassegue et al., 2012).  
Determining the subcellular region of NOX-4 is important because location and expression 
of NOX enzymes can dictate participation in distinct signaling pathways (Gough and Cotter, 
2011).  However, these data do not provide spatial or temporal information in regards to the 
specific subcellular location of NOX-4, or the origins of H2O2 in HCAEC following exposure 
to soluble UF.  In addition, activation of PG1 with H2O2 is irreversible so detection with this 
probe cannot be used to detect transient changes in H2O2 concentration (Rhee et al., 2010).  
Future studies using organelle-specific fluorescent probes or transduction with genetically-
encoded fluorescent indicators targeted towards specific cellular compartments that are 
reversible and highly specific for H2O2, will help elucidate the subcellular location of NOX-
4-induced H2O2 production (Rhee et al., 2010).  These data will further expand our 
knowledge regarding spatiotemporal and transient production of ROS following exposure to 
soluble UF in endothelial cells. 
Recently, a novel hierarchical cellular response model has been devised to explain the 
connection between oxidative stress and PM-induced cardiopulmonary adverse responses 
(Figure 5.1) (Li et al., 2008).  This is a 3-tier model that demonstrates increasing cellular 
damage with elevated levels of oxidative stress.  In this model, low levels of oxidative stress 
induce transcriptional activation of antioxidant and detoxification enzymes such as HO-1, 
catalase, superoxide, and glutathione peroxidase (Tier 1).  Activation of these antioxidants is 
a protective response, indicating PM-induced ROS production does not automatically cause 
cellular damage.  However, increased levels of oxidative stress can overwhelm these 
protective enzymes, resulting in inflammatory responses such as activation of 
proinflammatory cytokines, chemokines, and cell adhesion molecules (Tier 2).  Toxic levels 
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of oxidative stress involve the mitochondria, which can release pro-apoptotic factors that 
induce apoptosis (Tier 3).  Our project supports this cellular response model that was 
originally developed to estimate the adverse effects of diesel exhaust particle (DEP) exposure 
and extend it to include endothelial responses following exposure to the soluble components 
of UF particles.  We demonstrate that exposure to soluble UF increased extra- and 
intracellular ROS production in endothelial cells (Chapter 2 & 3), resulting in the 
upregulation of antioxidant enzymes (Tier 1; Chapter 4) and proinflammatory mediators 
(Tier 2; Chapter 4).  We do not see an increase in cytotoxicity following exposure, which 
would be the next step in this model, suggesting the doses used in this project induce 
endothelial activation rather than cellular death (Tier 3; Chapter 2).  This hierarchical cellular 
oxidative stress model provides a mechanistic pathway that may contribute to adverse 
cardiopulmonary responses following air particle exposure.  
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Figure 5.1 
 
Figure 5.1  Schematic diagram illustrating the hierarchical oxidative stress response.  
Image modified from Li et al. (Li et al., 2008). 
While it is uncertain whether whole UF particles can enter into the systemic 
circulation in humans, transition metals, which are major constituents of the water-soluble 
fraction of UF particles, can cross the thin alveolar-capillary membrane and cause direct 
effects on cells of the vasculature (Wallenborn et al., 2009; Wallenborn et al., 2007).  In vitro 
studies have illustrated that transition metals can detach from air pollution particles and 
subsequently be taken up by human lung epithelial cells to induce proinflammatory responses 
(Aust et al., 2002).  Transition metals are thought to play an important role in the adverse 
cardiopulmonary effects associated with air pollution exposure by increasing oxidative DNA 
damage, inducing ROS production, activating inflammatory pathways, and inducing 
procoagulant events (Costa and Dreher, 1997; Prahalad et al., 2001; Sangani et al., 2010; 
Sorensen et al., 2005; Wu et al., 2002).  We demonstrate in Chapter 2 that transition metals 
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are involved in the increased ROS production in endothelial cells following exposure to 
soluble UF.  These data support previous studies that determined transition metals increase 
ROS production leading to induction of inflammatory responses in pulmonary and vascular 
cells (Gojova et al., 2007; Montiel-Davalos et al., 2012; Shafer et al., 2010). Our results 
extend these observations by illustrating that transition metals associated with the soluble 
fraction of UF particles cause adverse vascular effects by inducing H2O2 production within 
endothelial cells.  This indicates that soluble components of PM are capable of inducing 
oxidative stress following exposure to air pollution.   
Potential follow up studies to this project would focus on determining the specific 
transition metal(s) responsible for these adverse effects.  Studies have shown that individual 
metal components like vanadium, copper, cadmium, iron, and zinc, which are present in our 
UF particles, induce adverse responses in in vitro models (Aust et al., 2002; Benton et al., 
2011; Cheng et al., 2010; Li et al., 2005).  Using inductively coupled plasma atomic emission 
spectroscopy to detect trace metals, it would be possible to determine the metal uptake in 
endothelial cells following exposure to the soluble UF (Deng et al., 2009).  Subsequently, 
endothelial cells can then be exposed to environmentally relevant doses of these transition 
metals to determine the role they play in endothelial activation.  These adverse responses are 
likely not the result of a single soluble component, but rather an unknown combination of 
transition metals.  The resulting data from these experiments would expand the current 
knowledge of how soluble UF components induce adverse CV health effects.  
NOX enzymes are an important source of ROS production in endothelial cells, and 
pathological activation of these enzymes can lead to oxidative stress and cellular injury 
(Brown and Griendling, 2009).  NOX-induced oxidative stress has been implicated in the 
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progression of several CV diseases including hypertension, atherosclerosis, and diabetes 
(Madamanchi et al., 2005).  In our studies, we showed that NOX enzymes are the major 
source of extracellular H2O2 production in endothelial cells following exposure to soluble UF 
(Chapter 2).  In addition, we demonstrated that ROS from NOX enzymes elevated 
endothelial procoagulant activity (Chapter 3), induced proinflammatory responses (Chapter 
4), and increased the expression of the oxidant sensitive molecule HO-1 in endothelial cells 
(Chapter 4).  These data expand upon the findings of previous studies that reported air 
pollution increases NOX-derived ROS that led to upregulation of TF mRNA expression in 
vascular smooth muscle cells (Cheng et al., 2010; Gorlach et al., 2000; Herkert and Gorlach, 
2002), contributed to proinflammatory responses in mouse pulmonary microvascular 
endothelial cells (Mo et al., 2009), and increased HO-1 mRNA expression in a human 
bronchial epithelial cell line (Cheng et al., 2010). 
It is interesting to note that neither pretreatment with DPI, a NOX inhibitor, nor 
deferoxamine, a metal chelator, completely attenuated extracellular H2O2 release in HCAEC 
exposed to soluble UF (Chapter 2).  These data imply that there is possibly another cellular 
source besides NOX enzymes generating ROS following soluble UF exposure in endothelial 
cells, and that there could be other soluble components besides transition metals inducing 
ROS production, respectively.  Another possibility is that transition metals, which are 
capable of generating ROS production independently through Fenton reactions (Jomova and 
Valko, 2011), are inducing ROS through an alternative pathway besides direct activation of 
NOX enzymes.  An ideal follow up experiment would involve exposing endothelial cells 
with soluble UF pretreated with deferoxamine in the presence of DPI.  If pretreatment with 
both DPI and deferoxamine completely attenuated soluble UF-induced ROS production, it 
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would indicate that transition metals are inducing ROS separate from the activation of NOX 
enzymes.  These data would further elucidate mechanisms that could link PM exposure to 
endothelial oxidative stress.   
Endothelial cells express mainly the NOX-2 and NOX-4 isoforms but expression 
levels of the NOX family members vary among the different endothelial cell types (Guzik et 
al., 2004).  HCAEC predominantly express the NOX-4 isoform but also express the NOX-2 
and NOX-1 homologs (Yoshida and Tsunawaki, 2008).  We demonstrated that transfection 
with NOX-4 siRNA attenuated soluble UF-induced TF mRNA expression (Chapter 3) and 
HO-1 mRNA expression (Chapter 4) in HCAEC.  However, there was not complete 
suppression of these soluble UF-induced mRNA increases, suggesting that another source 
besides NOX-4 is involved in the transcriptional regulation of these genes following 
exposure.  One possibility is that ROS from the NOX-2 enzyme plays a role in the 
augmented mRNA expression of TF and HO-1 following soluble UF exposure.  Similar to 
the NOX-4 isoform, NOX-2 in endothelial cells can also be involved in agonist-induced 
vascular oxidative stress (Bendall et al., 2007).  In addition, knockdown of either the NOX-4 
or NOX-2 enzyme with siRNA increases the mRNA and protein of the other isoform in 
endothelial cells (Pendyala et al., 2009).  This suggests a compensatory mechanism by the 
cell to ensure that basal levels of ROS can be produced for basic cellular processes.  Unlike 
NOX-4, which is a constitutively active enzyme, NOX-2 is an inducible enzyme that requires 
the translocation of several cytosolic subunits (Bedard and Krause, 2007).  Although these 
enzymes differ structurally, NOX-2 and NOX-4 both require the small membrane-associated 
component p22
phox
 for their catalytic activity (von Lohneysen et al., 2008).  Knockdown of 
p22
phox
attenuated ROS induced TF mRNA expression in vascular smooth muscle cells 
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activated by platelet-derived products (Gorlach et al., 2000). Future experiments that target 
this integral subunit in order to knockdown both NOX isoforms would provide additional 
data as to whether NOX-2 is involved in the adverse responses in HCAEC following soluble 
UF exposure. 
We show that transfection with NOX-4 siRNA attenuated TF mRNA expression 
following soluble UF exposure, which suggests that NOX-4 is the likely source of soluble 
UF-induced H2O2 production that results in increased endothelial procoagulant activity in 
HCAEC (Chapter 3).  However, we were unable to definitively illustrate that NOX-4 
knockdown in HCAEC attenuates the soluble UF-induced ROS production (Chapter 2 & 3) 
or faster onset of thrombin generation and fibrin thrombus formation (Chapter 3).  After 
several unsuccessful attempts at repeating the experiments with NOX-4 transfected cells, we 
determined that transfection with siRNA, regardless of whether it was scramble or targeted to 
NOX-4, slightly activated the endothelial cells to the point where our assays were not 
sensitive enough to detect the prospective diverse responses between the cells transfected 
with NOX-4 siRNA or scramble siRNA.  Follow up experiments to confirm the role of 
NOX-4-derived ROS production following soluble UF exposure could involve transducing 
HCAEC with a lentivirus containing a construct coded for a shRNA designed to knockdown 
NOX-4 gene expression in order to establish stable suppression of the NOX-4 enzyme.  
Recent studies have demonstrated that efficient, stable transduction with lentiviral vectors in 
primary endothelial cells is feasible (Pariente et al., 2008), and suggest that transduction with 
a NOX-4 lentivirus would help minimize cellular stress and activation prior to soluble UF 
exposure.   
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There is strong epidemiological evidence supporting a casual relationship between air 
particle pollution exposure and cardiovascular and cerebrovascular events triggered by 
thrombus formation, such as acute coronary syndrome, stroke, deep venous thrombosis, and 
thromboembolism (Baccarelli et al., 2008; Kettunen et al., 2007; Martinelli et al., 2012; 
Peters et al., 2001; Pope et al., 2006; Wellenius et al., 2012).  Endothelial activation and 
initiation of coagulation are pathophysiological mechanisms that could link inhaled air 
particle pollutants to vascular events (Figure 1.2).  We show that exposure to soluble UF 
induced a procoagulant phenotype in endothelial cells, supporting faster onset of thrombin 
generation and fibrin thrombus formation, and that these activities are driven by upregulation 
of TF (Chapter 3).  Activation of TF from injury or pathological conditions is typically 
balanced by expression of anticoagulant proteins such as TFPI, EPCR, and thrombomodulin 
(Crawley and Lane, 2008); however, our findings show lack of parallel upregulation of these 
anticoagulant proteins, resulting in a procoagulant environment that favors thrombin 
generation (Chapter 3).  Our data add to a growing body of evidence that link air pollution 
exposure to thrombosis.  Recent studies have demonstrated hypercoagulable effects of air 
pollution on thrombin generation in plasma samples taken from exposed human and animal 
models (Emmerechts et al., 2012; Kilinc et al., 2011; Rudez et al., 2009).  Our results extend 
these observations to potentially pathologic effects of PM on cellular procoagulant activity.  
The upregulation of TF and lack of compensatory changes in the anticoagulant proteins, 
which result in increased endothelial procoagulant activity, provide a mechanistic rationale 
for the increased cellular procoagulant activity following exposure to soluble UF.   
Activation of the extrinsic pathway via TF initiates a cascade of events that cumulates 
into the activation of fibrinogen into fibrin by thrombin, which is the basis of a fibrin 
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thrombus (Ott, 2011).  Abnormal fibrin structure and stability has been implicated in the 
progression of several CV diseases associated with thromboembolic events, including deep 
vein thrombosis, ischemic stroke, and coronary atherothrombosis (Collet et al., 2006; Lisman 
et al., 2005; Undas and Ariens, 2011).  High thrombin concentrations produce dense fibrin 
networks that are more resistant to fibrinolysis and more prone to thrombosis (Campbell et 
al., 2009).  Recent studies have demonstrated that endothelial cells also play a role in fibrin 
structure and stability (Campbell et al., 2009).  Primary human umbilical vein endothelial 
cells (HUVECs) exposed to the proinflammatory cytokines TNF-α and IL-1β, increased the 
rate of thrombin generation and fibrin thrombus formation in platelet-free plasma.  In 
addition, stimulation with the cytokines produced significantly denser fibrin networks than 
unstimulated HUVECs, indicating a more stable fibrin thrombus that is more resistant to 
fibrinolysis.  Addition of an anti-TF antibody to these cytokine-stimulated HUVECs 
attenuated the faster onset of thrombin generation, fibrin thrombus formation, and reduced 
the fibrin network density, indicating these events are TF-dependent.  These are similar 
findings to what we demonstrated in Chapter 3 after a more subtle stimulation with soluble 
UF.  These studies suggest that HCAEC exposed to soluble UF would produce denser fibrin 
structures that are more prone to thrombosis.  This would provide additional evidence that air 
particle exposure leads to an endothelial prothrombotic phenotype that results in adverse CV 
events associated with thromboembolisms.  Further experiments would need to be conducted 
in order to confirm this hypothesis.   
Increased inflammation plays a critical role in the development and progression of 
several CV disorders including diabetes (Navarro and Mora, 2006), chronic heart failure 
(Yndestad et al., 2006), and atherosclerosis (Libby, 2002).  Exposure to soluble UF increased 
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the expression of several proinflammatory mediators in HCAEC, which is a major indicator 
of endothelial activation (Chapter 4).  Our results add to a growing body of literature 
indicating that air pollution exposure leads to proinflammatory responses in humans (Ghio 
and Devlin, 2001), animal models (Ferraro et al., 2011), and in vitro models (Aung et al., 
2011; Fujii et al., 2001; van Eeden et al., 2001).  In addition, increasing epidemiological and 
experimental data have demonstrated that air pollution exposure is a risk factor for 
atherosclerosis (Araujo and Nel, 2009).  For instance, Kunzli et al. determined that for every 
10 μg/m3 rise in fine PM levels, there was a 5.9% increase in carotid intima-medial thickness, 
a measurement strongly associated with atherosclerosis (Kunzli et al., 2005).  Moreover, 
exposure to coarse PM accelerated progression of atherosclerotic lesions and increased 
vulnerability to plaque rupture in susceptible rabbit models (Suwa et al., 2002).  Endothelial 
activation is an underlying event in the initiation and progression of atherosclerosis through 
expression of proinflammatory cytokines and cell adhesion molecules, which attract and 
provide a pathway for leukocyte trafficking during lesion progression (Libby et al., 2006).  
Our data demonstrated that soluble UF exposure in endothelial cells induced expression of 
several key proinflammatory cytokines (MCP-1, IL-8, GM-CSF) and cell adhesion molecules 
(ICAM-1) involved in the initiation and progression of atherosclerosis (Chapter 4).  For 
example, increased expression of ICAM-1 on the surface of endothelial cells promotes the 
adherence of monocytes during initiation of atherogenesis (Szmitko et al., 2003). MCP-1 and 
IL-8 are chemoattractant cytokines that promote migration of inflammatory cells during 
initiation and progression of atherosclerotic lesions (Apostolopoulos et al., 1996; Harrington, 
2000).  Furthermore, GM-CSF can enable macrophage maturation and activation during 
atherogenesis (Smith et al., 1995).  Increased expression of these proinflammatory mediators 
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in endothelial cells following exposure to soluble UF both support and extend vital 
information regarding mechanisms by which PM exposure results in the development and 
progression of atherosclerosis.   
The elevated expression of TF, proinflammatory cytokines, adhesion molecules, and 
HO-1 (Chapter 3 & 4), indicate that exposure to soluble UF leads to endothelial activation in 
cultured primary endothelial cells (Hunt and Jurd, 1998).  Transcriptional regulation of a 
number of genes studied in this project are known to be redox-sensitive (Haddad, 2002; 
Herkert et al., 2004; Lavrovsky et al., 2000; Motterlini et al., 2002; Tak and Firestein, 2001).  
ROS is thought to induce gene expression changes through activation of redox-regulated 
transcription factors, such as NF-κB, AP-1, SP1, and Nrf2 (Herkert and Gorlach, 2002; 
Lavrovsky et al., 2000; Li et al., 2011).  The TF gene in primary endothelial cells has been 
shown to contain binding sites for the redox-sensitive transcription factors NF-κB, AP-1, and 
SP1 (Herkert and Gorlach, 2002; Moll et al., 1995).  It is interesting to note that although 
expression of TF can be regulated by the same transcription factors that can control the 
anticoagulant proteins and proinflammatory mediators examined in this project, our data 
indicates that the expression of these genes were not regulated by NOX-4-derived ROS 
following exposure to soluble UF (Chapter 3 & 4).  These data suggest activation of an 
independent mechanistic pathway specific for TF; however, further experiments must be 
conducted in order to elucidate the transcriptional regulation involved in the augmented 
expression of TF following exposure to soluble UF.  
The data from this project illustrated that soluble UF exposure increased NOX-
derived ROS production (Chapter 2) leading to cellular oxidative stress (Figure 5.1) that 
regulated procoagulant (Chapter 3) and proinflammatory mediators (Chapter 4), resulting in 
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endothelial activation and a prothrombotic phenotype (Figure 1.6).  Combating oxidative 
stress by targeting ROS or the oxidant source is becoming an apparent approach for treatment 
of CV disease.    Increasing antioxidant capacity through pharmacological induction or 
overexpression in order to reduce endothelial oxidative stress is a therapeutic strategy used to 
restore normal endothelial function (Sharma et al., 2012).  For example, induction of the 
antioxidant HO-1 in human aortic endothelial cells attenuated the induced proinflammatory 
effects and endothelial dysfunction caused by agonist-induced exposure (Kawamura et al., 
2005).  In addition, there are numerous epidemiological studies demonstrating that dietary 
and supplemental intake of antioxidant vitamins leads to the reduction of atherogenesis (Diaz 
et al., 1997).  Moreover, NOX enzymes are key sources of vascular oxidative stress, and are 
emerging as a potential therapeutic target in the limitation of excessive ROS production 
(Schramm et al., 2012).  For instance, newly developed pharmacological inhibitors of NOX-4 
(VAS2870 and GKT-136901) have been shown to attenuate agonist-induced oxidative stress 
in mouse kidney proximal tubule cells (Sedeek et al., 2010) and vascular smooth muscle cells 
(ten Freyhaus et al., 2006).  In general, our findings further support the targeting of ROS, 
either through increases in antioxidant capacity or direct inhibition of NOX enzymes, which 
are both viable therapeutic strategies to combat air pollutant-induced adverse CV effects.   
It is our belief that this project contributes to the scientific literature addressing the 
mechanisms behind the association between exposure to air particle pollution and CV 
disease.  We demonstrate that exposure to the soluble components of UF particles induce 
ROS production in endothelial cells from NOX enzymes that was dependent on transition 
metals.  This PM-induced oxidative stress led to endothelial activation as characterized by 
elevated expression of proinflammatory mediators and increased endothelial procoagulant 
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activity.  These novel findings support and extend important information regarding 
mechanisms by which PM exposure results in endothelial activation and initiation of 
coagulation, which may contribute to adverse CV health effects mediated by thrombosis.    
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